| Code | Display | Comments |
|---|
 1-8 | Acyclovir [Susceptibility] | | |
| 10-9 | Amdinocillin [Susceptibility] by Serum bactericidal titer | | |
| 100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
| 1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 100019-9 | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
| 100020-7 | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
| 100021-5 | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
| 100022-3 | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
| 100023-1 | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
| 100024-9 | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
| 100025-6 | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
| 100026-4 | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
| 100027-2 | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
| 100028-0 | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
| 100029-8 | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method | | |
| 100041-3 | Aminoglycoside [Susceptibility] | | |
| 100042-1 | Atovaquone [Susceptibility] | | |
| 100043-9 | Azithromycin+Ethambutol [Susceptibility] | | |
| 100044-7 | Cefcapene [Susceptibility] | | |
| 100045-4 | Cefozopran [Susceptibility] | | |
| 100046-2 | Cefquinome [Susceptibility] | | |
| 100047-0 | Cefteram [Susceptibility] | | |
| 100048-8 | Clarithromycin+Ethambutol [Susceptibility] | | |
| 100049-6 | Eravacycline [Susceptibility] | | |
| 100050-4 | Erythromycin+Ethambutol [Susceptibility] | | |
| 100051-2 | Ethambutol+rifAMPin [Susceptibility] | | |
| 100052-0 | Flomoxef [Susceptibility] | | |
| 100053-8 | Fluoroquinolone [Susceptibility] | | |
| 100054-6 | Gamithromycin [Susceptibility] | | |
| 100055-3 | Optochin [Susceptibility] | | |
| 100056-1 | Panipenem [Susceptibility] | | |
| 100057-9 | Prothionamide [Susceptibility] | | |
| 100058-7 | Prulifloxacin [Susceptibility] | | |
| 100059-5 | Rifapentine [Susceptibility] | | |
| 100060-3 | Tildipirosin [Susceptibility] | | |
| 100061-1 | Tosufloxacin [Susceptibility] | | |
| 100087-6 | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100088-4 | Taenia solium larva Ab bands panel - Serum by Immunoblot | | |
| 100089-2 | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot | | |
| 100090-0 | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot | | |
| 100091-8 | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay | | |
| 100092-6 | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot | | |
| 100093-4 | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100094-2 | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100095-9 | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100096-7 | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100097-5 | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100098-3 | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100099-1 | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 1001-7 | DBG Ab [Presence] in Serum or Plasma from Donor | | |
| 100100-7 | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay | | |
| 100101-5 | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100102-3 | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100103-1 | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100104-9 | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100105-6 | Filaria IgG and IgM panel - Serum | | |
| 100106-4 | Filaria IgG Ab [Presence] in Serum by Immunoassay | | |
| 100107-2 | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay | | |
| 100108-0 | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay | | |
| 100109-8 | Leishmania sp Ab bands panel - Serum by Immunoblot | | |
| 100110-6 | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100111-4 | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot | | |
| 100112-2 | Fasciola sp Ab bands panel - Serum by Immunoblot | | |
| 100113-0 | Helicobacter pylori Ab panel - Serum | | |
| 100114-8 | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot | | |
| 100115-5 | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot | | |
| 100116-3 | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot | | |
| 100117-1 | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot | | |
| 100118-9 | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot | | |
| 100119-7 | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot | | |
| 100120-5 | Chlamydia trachomatis Ab panel - Serum | | |
| 100121-3 | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay | | |
| 100122-1 | Chlamydophila pneumoniae Ab panel - Serum | | |
| 100123-9 | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay | | |
| 100124-7 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay | | |
| 100125-4 | Chlamydophila psittaci Ab panel - Serum | | |
| 100126-2 | Bordetella pertussis Ab.IgG panel - Serum | | |
| 100127-0 | Campylobacter sp Ab panel - Serum | | |
| 100128-8 | Cryptococcus sp Ag panel - Serum | | |
| 100129-6 | Schistosoma sp Ab [Titer] in Serum by Hemagglutination | | |
| 100130-4 | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot | | |
| 100131-2 | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot | | |
| 100132-0 | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot | | |
| 100133-8 | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot | | |
| 100134-6 | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot | | |
| 100135-3 | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot | | |
| 100136-1 | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot | | |
| 100137-9 | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot | | |
| 100138-7 | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot | | |
| 100139-5 | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot | | |
| 100140-3 | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot | | |
| 100141-1 | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot | | |
| 100142-9 | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot | | |
| 100143-7 | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot | | |
| 100144-5 | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot | | |
| 100145-2 | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot | | |
| 100146-0 | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot | | |
| 100147-8 | Toxoplasma gondii Ab bands panel - Serum by Immunoblot | | |
| 100148-6 | Schistosoma sp Ab bands panel - Serum by Immunoblot | | |
| 100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma | | |
| 100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma | | |
| 100151-0 | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma | | |
| 100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | | |
| 100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | | |
| 100154-4 | Specimen collection supervision level | | |
| 100156-9 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection | | |
| 100157-7 | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing | | |
| 100158-5 | Microalbumin [Mass/volume] in Urine collected for unspecified duration | | |
| 1002-5 | DBG Ab [Presence] in Serum or Plasma | | |
| 100213-8 | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method | | |
| 100281-5 | D Ab [Units/volume] in Serum or Plasma | | |
| 1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | | |
| 100305-2 | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | | |
| 100306-0 | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | | |
| 100341-7 | Rubella virus IgG Ab index [Units/volume] in Serum and CSF | | |
| 100342-5 | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry | | |
| 100343-3 | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | | |
| 100344-1 | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | | |
| 100345-8 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection | | |
| 100346-6 | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG | | |
| 100347-4 | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG | | |
| 100350-8 | Sesamum indicum 1 IgE Ab [Units/volume] in Serum | | |
| 100351-6 | Pioglitazone [Presence] in Serum or Plasma | | |
| 100352-4 | Rosiglitazone [Presence] in Serum or Plasma | | |
| 100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection | | |
| 100357-3 | Naloxone [Presence] in Cord tissue by Screen method | | |
| 100358-1 | Phentermine [Presence] in Cord tissue by Screen method | | |
| 100359-9 | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay | | |
| 100368-0 | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS | | |
| 100370-6 | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection | | |
| 100371-4 | Titin Ab [Units/volume] in Serum by Immunoassay | | |
| 100372-2 | Abiraterone [Mass/volume] in Serum or Plasma | | |
| 100373-0 | Eucheuma IgG Ab [Units/volume] in Serum | | |
| 100374-8 | Aloe vera IgG Ab [Units/volume] in Serum | | |
| 100375-5 | Anise IgG Ab [Units/volume] in Serum | | |
| 100376-3 | Bambusa vulgaris IgG Ab [Units/volume] in Serum | | |
| 100377-1 | Goat cheese IgG Ab [Units/volume] in Serum | | |
| 100378-9 | Sheep cheese IgG Ab [Units/volume] in Serum | | |
| 100379-7 | Leeks IgG Ab [Units/volume] in Serum | | |
| 100380-5 | Red cabbage IgG Ab [Units/volume] in Serum | | |
| 100381-3 | Mentha balsamea Wild IgG Ab [Units/volume] in Serum | | |
| 100383-9 | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | | |
| 100384-7 | Rapeseed IgG Ab [Units/volume] in Serum | | |
| 100385-4 | Corn salad IgG Ab [Units/volume] in Serum | | |
| 100386-2 | Rosemary IgG Ab [Units/volume] in Serum | | |
| 100387-0 | Poppy Seed IgG Ab [Units/volume] in Serum | | |
| 100388-8 | Cocoa IgG Ab [Units/volume] in Serum | | |
| 100389-6 | Pistachio IgG Ab [Units/volume] in Serum | | |
| 100390-4 | Sunflower Seed IgG Ab [Units/volume] in Serum | | |
| 100391-2 | Dates IgG Ab [Units/volume] in Serum | | |
| 100392-0 | Duck meat IgG Ab [Units/volume] in Serum | | |
| 100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum | | |
| 100394-6 | Astacoidea IgG Ab [Units/volume] in Serum | | |
| 100395-3 | Carob IgG Ab [Units/volume] in Serum | | |
| 100396-1 | Brassica napus IgG Ab [Units/volume] in Serum | | |
| 100397-9 | Goat Meat IgG Ab [Units/volume] in Serum | | |
| 100398-7 | Goose meat IgG Ab [Units/volume] in Serum | | |
| 100399-5 | Ostrich meat IgG Ab [Units/volume] in Serum | | |
| 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | | |
| 100400-1 | Quail meat IgG Ab [Units/volume] in Serum | | |
| 100401-9 | Rabbit meat IgG Ab [Units/volume] in Serum | | |
| 100402-7 | Venison meat IgG Ab [Units/volume] in Serum | | |
| 100403-5 | Guineafowl IgG Ab [Units/volume] in Serum | | |
| 100404-3 | Horse meat IgG Ab [Units/volume] in Serum | | |
| 100405-0 | Kefir IgG Ab [Units/volume] in Serum | | |
| 100406-8 | Butter IgG Ab [Units/volume] in Serum | | |
| 100407-6 | Camembert cheese IgG Ab [Units/volume] in Serum | | |
| 100408-4 | Emmental cheese IgG Ab [Units/volume] in Serum | | |
| 100409-2 | Processed cheese IgG Ab [Units/volume] in Serum | | |
| 100410-0 | Curd cheese IgG Ab [Units/volume] in Serum | | |
| 100411-8 | Sugar Beet IgG Ab [Units/volume] in Serum | | |
| 100412-6 | Chinese cabbage IgG Ab [Units/volume] in Serum | | |
| 100413-4 | Fennel Fresh IgG Ab [Units/volume] in Serum | | |
| 100414-2 | Gourd IgG Ab [Units/volume] in Serum | | |
| 100415-9 | Kale IgG Ab [Units/volume] in Serum | | |
| 100416-7 | Savoy cabbage IgG Ab [Units/volume] in Serum | | |
| 100417-5 | Vitis sp leaf IgG Ab [Units/volume] in Serum | | |
| 100418-3 | Liquorice IgG Ab [Units/volume] in Serum | | |
| 100419-1 | Snow pea IgG Ab [Units/volume] in Serum | | |
| 100420-9 | Fava bean IgG Ab [Units/volume] in Serum | | |
| 100421-7 | Chick Pea IgG Ab [Units/volume] in Serum | | |
| 100422-5 | Chicory IgG Ab [Units/volume] in Serum | | |
| 100423-3 | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum | | |
| 100424-1 | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma | | |
| 100425-8 | DiHydro T-Mas [Mass/volume] in Serum or Plasma | | |
| 100426-6 | Squalene [Mass/volume] in Serum or Plasma | | |
| 100427-4 | Stigmasterol [Mass/volume] in Serum or Plasma | | |
| 100428-2 | Carnitine free and total and acylcarnitine panel - Urine | | |
| 100429-0 | LRBA deficiency panel - Blood | | |
| 100430-8 | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) | | |
| 100431-6 | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | | |
| 100432-4 | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) | | |
| 100433-2 | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | | |
| 100434-0 | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection | | |
| 100435-7 | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay | | |
| 100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay | | |
| 100437-3 | Norsufentanil [Mass/volume] in Urine by Confirmatory method | | |
| 1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma | | |
| 1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells | | |
| 100654-3 | Pyruvate kinase M2 [Presence] in Stool | | |
| 100662-6 | Cortisol free and total panel - Serum or Plasma | | |
| 100663-4 | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method | | |
| 100664-2 | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method | | |
| 100665-9 | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method | | |
| 100666-7 | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method | | |
| 100667-5 | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method | | |
| 100668-3 | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method | | |
| 100669-1 | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method | | |
| 100670-9 | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus | | |
| 100671-7 | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection | | |
| 100672-5 | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection | | |
| 100673-3 | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection | | |
| 100674-1 | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
| 100675-8 | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | | |
| 100676-6 | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection | | |
| 100677-4 | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
| 100678-2 | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
| 100679-0 | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
| 100680-8 | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
| 100681-6 | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
| 100682-4 | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
| 100683-2 | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
| 100684-0 | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
| 100685-7 | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
| 100686-5 | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | | |
| 100687-3 | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection | | |
| 100688-1 | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
| 100689-9 | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection | | |
| 100690-7 | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection | | |
| 100691-5 | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
| 100692-3 | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | | |
| 100693-1 | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory specimen by NAA with probe detection | | |
| 100694-9 | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method | | |
| 100695-6 | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative | | |
| 100696-4 | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal | | |
| 100699-8 | Rifabutin+Ethambutol [Susceptibility] | | |
| 1007-4 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells | | |
| 100700-4 | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection | | |
| 100701-2 | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection | | |
| 100702-0 | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection | | |
| 100703-8 | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection | | |
| 100704-6 | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection | | |
| 100705-3 | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection | | |
| 100706-1 | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection | | |
| 100707-9 | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count | | |
| 100708-7 | Plasma cells/100 leukocytes in Synovial fluid | | |
| 100709-5 | Hepatocellular carcinoma risk [Score] by GAAD | | |
| 100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection | | |
| 100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay | | |
| 100712-9 | Brexpiprazole [Mass/volume] in Serum or Plasma | | |
| 100713-7 | Cariprazine [Mass/volume] in Serum or Plasma | | |
| 100714-5 | Guanfacine [Mass/volume] in Serum or Plasma | | |
| 100715-2 | Prothipendyl [Mass/volume] in Serum or Plasma | | |
| 100716-0 | Prostate specific Ag [Mass/volume] in DBS | | |
| 100717-8 | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method | | |
| 100732-7 | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum | | |
| 100733-5 | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) | | |
| 100734-3 | traMADol and Metabolites Panel - Urine by Confirmatory method | | |
| 100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes | | |
| 100736-8 | Acylcarnitine Analysis Post Mortem in Specimen Document | | |
| 100737-6 | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma | | |
| 100738-4 | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma | | |
| 100739-2 | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma | | |
| 100740-0 | Amylase.macromolecular [Presence] in Serum or Plasma | | |
| 100741-8 | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma | | |
| 100742-6 | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma | | |
| 100743-4 | Lipase.macromolecular [Presence] in Serum or Plasma | | |
| 100744-2 | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis | | |
| 100745-9 | Chloride [Moles/volume] in Mixed venous blood | | |
| 100746-7 | Glucose [Moles/volume] in Mixed venous blood | | |
| 100747-5 | Legionella serogroup panel - Specimen | | |
| 100748-3 | Legionella spp [Presence] in Specimen by NAA with probe detection | | |
| 100749-1 | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection | | |
| 100750-9 | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection | | |
| 100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma | | |
| 100754-1 | Platelet disorders multigene analysis in Blood or Tissue by Sequencing | | |
| 100755-8 | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing | | |
| 100756-6 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing | | |
| 100757-4 | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing | | |
| 100761-6 | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | | |
| 100762-4 | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method | | |
| 100763-2 | Mycobacterium sp comparative reaction interpretation Narrative | | |
| 100764-0 | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal | | |
| 100765-7 | Homocysteine and methylmalonate and methylcitrate panel - DBS | | |
| 100788-9 | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum | | |
| 100789-7 | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum | | |
| 100790-5 | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum | | |
| 100791-3 | Hamster epithelium IgG Ab [Mass/volume] in Serum | | |
| 100792-1 | Forsythia IgE Ab [Units/volume] in Serum | | |
| 100793-9 | Testosterone [Mass/volume] in Body fluid | | |
| 100794-7 | Follitropin [Units/volume] in Body fluid | | |
| 100795-4 | S100 calcium binding protein B [Mass/volume] in Body fluid | | |
| 100796-2 | Thyroglobulin [Mass/volume] in Body fluid | | |
| 100797-0 | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge | | |
| 100798-8 | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge | | |
| 100799-6 | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge | | |
| 1008-2 | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma | | |
| 100800-2 | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge | | |
| 100801-0 | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge | | |
| 100802-8 | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge | | |
| 100803-6 | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge | | |
| 100804-4 | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge | | |
| 100805-1 | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge | | |
| 100806-9 | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge | | |
| 100807-7 | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge | | |
| 100808-5 | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge | | |
| 100809-3 | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge | | |
| 100810-1 | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge | | |
| 100811-9 | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge | | |
| 100812-7 | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge | | |
| 100813-5 | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge | | |
| 100814-3 | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge | | |
| 100815-0 | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge | | |
| 100816-8 | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | | |
| 100817-6 | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | | |
| 100818-4 | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge | | |
| 100819-2 | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge | | |
| 100820-0 | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge | | |
| 100829-1 | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge | | |
| 100830-9 | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge | | |
| 100831-7 | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge | | |
| 100832-5 | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge | | |
| 100833-3 | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge | | |
| 100834-1 | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge | | |
| 100835-8 | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge | | |
| 100836-6 | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge | | |
| 100837-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | | |
| 100838-2 | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | | |
| 100839-0 | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma | | |
| 100840-8 | IgE [Units/volume] in Body fluid | | |
| 100841-6 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot | | |
| 100842-4 | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST | | |
| 100843-2 | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ | | |
| 100844-0 | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 | | |
| 100845-7 | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) | | |
| 100846-5 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay | | |
| 100847-3 | Gas and ammonia panel - Arterial blood | | |
| 100848-1 | Cell count and Differential panel - Amniotic fluid by Manual count | | |
| 100849-9 | Leukocytes [#/volume] in Amniotic fluid by Manual count | | |
| 100850-7 | Neutrophils [#/volume] in Amniotic fluid by Manual count | | |
| 100851-5 | Other cells [#/volume] in Amniotic fluid by Manual count | | |
| 100854-9 | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay | | |
| 100855-6 | CD3 cells/100 cells in Blood mononuclear cells | | |
| 100856-4 | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells | | |
| 100857-2 | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells | | |
| 100858-0 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | | |
| 100859-8 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | | |
| 100860-6 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | | |
| 100861-4 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | | |
| 100862-2 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | | |
| 100863-0 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | | |
| 100864-8 | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method | | |
| 100865-5 | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection | | |
| 100866-3 | Febrile antibody profile in Serum | | |
| 100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay | | |
| 100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method | | |
| 100869-7 | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method | | |
| 100870-5 | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method | | |
| 100871-3 | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method | | |
| 100872-1 | Bacteria producing polysaccharide from sucrose [Presence] in Isolate | | |
| 100873-9 | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method | | |
| 100874-7 | Basidiobolus sp [Presence] in Specimen | | |
| 100885-3 | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection | | |
| 100886-1 | Orf virus DNA [Presence] in Specimen by NAA with probe detection | | |
| 100887-9 | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection | | |
| 100888-7 | West African monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | | |
| 100889-5 | Congo Basin monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | | |
| 100890-3 | Poxvirus DNA panel | | |
| 100891-1 | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay | | |
| 100892-9 | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay | | |
| 100893-7 | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma | | |
| 100895-2 | Rickettsia conorii IgG and IgM [Interpretation] in Serum | | |
| 100896-0 | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge | | |
| 100897-8 | Staphylococcus aureus [Presence] in Specimen by Organism specific culture | | |
| 100898-6 | Lipid panel - Serum or Plasma | | |
| 100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture | | |
| 1009-0 | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells | | |
| 100900-0 | Enterobacteriaceae.carbapenem resistance panel - Anal by Organism specific culture | | |
| 100901-8 | Enterobacteriaceae.carbapenemase resistance phenotype [Identifier] in Anal by Organism specific culture | | |
| 100902-6 | Enterobacteriaceae.carbapenemase resistance phenotype.OXA-48 [Identifier] in Anal by Organism specific culture | | |
| 100903-4 | Yeast and Candida sp identification panel - Specimen by Organism specific culture | | |
| 100904-2 | Urinary tract pathogens panel - Urine by Culture | | |
| 100905-9 | Gram positive bacteria identified in Isolate by Organism specific culture | | |
| 100906-7 | Bacteria [#/volume] in Urine by Culture | | |
| 100907-5 | Vancomycin resistant enterococcus [Identifier] in Specimen by Organism specific culture | | |
| 100908-3 | Pseudomonas aeruginosa [Presence] in Lower respiratory specimen by Organism specific culture | | |
| 100909-1 | Cronobacter sakazakii [Presence] by Organism specific culture | | |
| 100910-9 | Gram negative bacteria.colistin resistant identified in Stool by Organism specific culture | | |
| 100911-7 | Campylobacter sp [Presence] in Stool by Organism specific culture | | |
| 100912-5 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype and Enterococcus species.vancomycin resistant panel | | |
| 100913-3 | Staph aureus and MRSA screening panel - Specimen by Organism specific culture | | |
| 100914-1 | Protein.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis | | |
| 100915-8 | Burr cells [Presence] in Body fluid by Light microscopy | | |
| 100962-0 | Dengue virus Ab.IgG Panel - Serum, Plasma or Blood | | |
| 100963-8 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | | |
| 100964-6 | Dengue virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | | |
| 100965-3 | Dengue virus IgG Ab [Interpretation] in Serum, Plasma or Blood | | |
| 100968-7 | Bovine tuberculosis comparative cervical test panel - Skin | | |
| 101-6 | Cefoperazone [Susceptibility] by Disk diffusion (KB) | | |
| 1010-8 | E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 1011-6 | E sup(w) Ab [Presence] in Serum or Plasma from Donor | | |
| 1012-4 | E sup(w) Ab [Presence] in Serum or Plasma | | |
| 1013-2 | E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 1014-0 | E sup(w) Ag [Presence] on Red Blood Cells from Donor | | |
| 1015-7 | E sup(w) Ag [Presence] on Red Blood Cells | | |
| 1016-5 | E Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 1017-3 | E Ab [Presence] in Serum or Plasma from Donor | | |
| 1018-1 | E Ab [Presence] in Serum or Plasma | | |
| 1019-9 | E Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 102-4 | Cefoperazone [Susceptibility] by Serum bactericidal titer | | |
| 1020-7 | E Ag [Presence] on Red Blood Cells from Donor | | |
| 1021-5 | E Ag [Presence] on Red Blood Cells | | |
| 1022-3 | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 10226-9 | Oxygen content in Intravascular space | | |
| 1023-1 | Fy sup(a) Ab [Presence] in Serum or Plasma from Donor | | |
| 10232-7 | Oxygen content in Aorta root | | |
| 10233-5 | Oxygen content in Left atrium | | |
| 10234-3 | Oxygen content in Right atrium | | |
| 10235-0 | Oxygen content in High right atrium | | |
| 10236-8 | Oxygen content in Low right atrium | | |
| 10237-6 | Oxygen content in Mid right atrium | | |
| 10238-4 | Oxygen content in Left ventricle | | |
| 10239-2 | Oxygen content in Right ventricular outflow tract | | |
| 1024-9 | Fy sup(a) Ab [Presence] in Serum or Plasma | | |
| 10240-0 | Oxygen content in Right ventricle | | |
| 10241-8 | Oxygen content in Coronary sinus | | |
| 10242-6 | Oxygen content in Ductus arteriosus | | |
| 10243-4 | Oxygen content in Inferior vena cava | | |
| 10244-2 | Oxygen content in Left pulmonary artery | | |
| 10245-9 | Oxygen content in Main pulmonary artery | | |
| 10246-7 | Oxygen content in Right pulmonary artery | | |
| 10247-5 | Oxygen content in Pulmonary wedge | | |
| 10248-3 | Oxygen content in Superior vena cava | | |
| 1025-6 | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 1026-4 | Fy sup(a) Ag [Presence] on Red Blood Cells from Donor | | |
| 1027-2 | Fy sup(a) Ag [Presence] on Red Blood Cells | | |
| 1028-0 | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 1029-8 | Fy sup(b) Ab [Presence] in Serum or Plasma from Donor | | |
| 103-2 | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) | | |
| 1030-6 | Fy sup(b) Ab [Presence] in Serum or Plasma | | |
| 1031-4 | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 1032-2 | Fy sup(b) Ag [Presence] on Red Blood Cells from Donor | | |
| 10327-5 | Eosinophils/100 leukocytes in Sputum by Manual count | | |
| 10328-3 | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count | | |
| 10329-1 | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count | | |
| 1033-0 | Fy sup(b) Ag [Presence] on Red Blood Cells | | |
| 10330-9 | Monocytes/100 leukocytes in Body fluid by Manual count | | |
| 10331-7 | Rh [Type] in Blood | | |
| 10332-5 | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM | | |
| 10333-3 | Appearance of Cerebral spinal fluid | | |
| 10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma | | |
| 10335-8 | Color of Cerebral spinal fluid | | |
| 10336-6 | Gonadotropin peptide [Mass/volume] in Urine | | |
| 10337-4 | Procollagen type I [Mass/volume] in Serum | | |
| 10338-2 | Barbiturates [Mass/volume] in Serum or Plasma | | |
| 10339-0 | FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | | |
| 1034-8 | Fetal cell screen [Interpretation] in Blood | | |
| 10340-8 | Molindone [Mass/volume] in Serum or Plasma | | |
| 10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma | | |
| 10342-4 | Sulfamethoxazole [Mass/volume] in Serum or Plasma | | |
| 10343-2 | Temazepam [Mass/volume] in Serum or Plasma | | |
| 10344-0 | Tranylcypromine [Mass/volume] in Serum or Plasma | | |
| 10345-7 | Trihexyphenidyl [Mass/volume] in Urine | | |
| 10346-5 | Hemoglobin A [Units/volume] in Blood by Electrophoresis | | |
| 10347-3 | Babesia microti identified in Blood by Light microscopy | | |
| 10348-1 | Bordetella parapertussis Ab [Presence] in Serum | | |
| 10349-9 | Brucella sp Ab [Units/volume] in Serum | | |
| 1035-5 | Fresh frozen plasma given [Volume] | | |
| 10350-7 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay | | |
| 10351-5 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | | |
| 10352-3 | Bacteria identified in Genital specimen by Aerobe culture | | |
| 10353-1 | Bacteria identified in Nose by Aerobe culture | | |
| 10354-9 | Bacteria identified in Urethra by Culture | | |
| 10355-6 | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain | | |
| 10356-4 | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain | | |
| 10357-2 | Microscopic observation [Identifier] in Wound by Gram stain | | |
| 10358-0 | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) | | |
| 10359-8 | Asialoganglioside GM1 IgM Ab [Titer] in Serum | | |
| 1036-3 | G Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 10360-6 | DNA single strand IgG Ab [Units/volume] in Serum | | |
| 10361-4 | DNA single strand IgM Ab [Units/volume] in Serum | | |
| 10362-2 | Endomysium IgA Ab [Presence] in Serum | | |
| 10363-0 | Barbiturates [Presence] in Specimen | | |
| 10364-8 | Cotinine [Mass/mass] in Hair | | |
| 10365-5 | Cotinine [Mass/volume] in Serum or Plasma | | |
| 10366-3 | Cotinine [Mass/volume] in Urine | | |
| 10367-1 | Ethanol [Mass/volume] in Gastric fluid | | |
| 10368-9 | Lead [Mass/volume] in Capillary blood | | |
| 10369-7 | Opiates [Mass/mass] in Hair | | |
| 1037-1 | G Ab [Presence] in Serum or Plasma from Donor | | |
| 10370-5 | Phencyclidine [Mass/mass] in Hair | | |
| 10371-3 | Bite cells [Presence] in Blood by Light microscopy | | |
| 10372-1 | Blister cells [Presence] in Blood by Light microscopy | | |
| 10373-9 | Fragments [Presence] in Blood by Light microscopy | | |
| 10374-7 | Helmet cells [Presence] in Blood by Light microscopy | | |
| 10375-4 | Irregularly contracted cells [Presence] in Blood by Light microscopy | | |
| 10376-2 | Oval macrocytes [Presence] in Blood by Light microscopy | | |
| 10377-0 | Pencil cells [Presence] in Blood by Light microscopy | | |
| 10378-8 | Polychromasia [Presence] in Blood by Light microscopy | | |
| 10379-6 | Erythrocytes.dual population [Presence] in Blood by Light microscopy | | |
| 1038-9 | G Ab [Presence] in Serum or Plasma | | |
| 10380-4 | Stomatocytes [Presence] in Blood by Light microscopy | | |
| 10381-2 | Target cells [Presence] in Blood by Light microscopy | | |
| 10382-0 | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 10383-8 | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Donor | | |
| 10384-6 | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells | | |
| 10385-3 | Albumin concentration given | | |
| 10386-1 | Albumin given [Volume] | | |
| 10387-9 | Autologous erythrocytes given [Volume] | | |
| 10388-7 | Autologous whole blood given [Volume] | | |
| 10389-5 | Blood product.other [Type] | | |
| 1039-7 | G Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 10390-3 | Blood product special preparation [Type] | | |
| 10391-1 | Cytomegalovirus immune globulin given [Volume] | | |
| 10392-9 | Cryoprecipitate given [Volume] | | |
| 10393-7 | Factor IX given [Type] | | |
| 10394-5 | Factor IX given [Volume] | | |
| 10395-2 | Factor VIII given [Type] | | |
| 10396-0 | Factor VIII given [Volume] | | |
| 10397-8 | Hepatitis B immune globulin given [Volume] | | |
| 10398-6 | I Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 10399-4 | I Ag [Presence] on Red Blood Cells from Donor | | |
| 104-0 | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
| 1040-5 | G Ag [Presence] on Red Blood Cells from Donor | | |
| 10400-0 | I Ag [Presence] on Red Blood Cells | | |
| 10401-8 | Immune serum globulin given [Type] | | |
| 10402-6 | Immune serum globulin given [Volume] | | |
| 10403-4 | Inject immune serum globulin [Volume] | | |
| 10404-2 | Inject Rh immune globulin [Volume] | | |
| 10405-9 | Inject varicella zoster virus immune globulin [Volume] | | |
| 10406-7 | little i Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 10407-5 | little i Ag [Presence] on Red Blood Cells from Donor | | |
| 10408-3 | little i Ag [Presence] on Red Blood Cells | | |
| 10409-1 | Pentaspan given [Volume] | | |
| 1041-3 | G Ag [Presence] on Red Blood Cells | | |
| 10410-9 | Plasma given [Type] | | |
| 10411-7 | Plasma given [Volume] | | |
| 10412-5 | Platelets given [Type] | | |
| 10413-3 | Rh immune globulin given [Volume] | | |
| 10414-1 | Transfuse albumin [Volume] | | |
| 10415-8 | Transfuse blood exchange transfusion [Volume] | | |
| 10416-6 | Transfuse blood product other [Volume] | | |
| 10417-4 | Transfuse cryoprecipitate [Volume] | | |
| 10418-2 | Transfuse factor IX [Volume] | | |
| 10419-0 | Transfuse factor VIII [Volume] | | |
| 1042-1 | H Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 10420-8 | Transfuse immune serum globulin [Volume] | | |
| 10421-6 | Transfuse Pentaspan [Volume] | | |
| 10422-4 | Transfuse plasma [Volume] | | |
| 10423-2 | Transfuse platelets [Volume] | | |
| 10424-0 | Transfuse erythrocytes [Volume] | | |
| 10425-7 | Transfuse Rh immune globulin [Volume] | | |
| 10426-5 | Transfuse whole blood [Volume] | | |
| 10427-3 | Transfuse whole blood autologous [Volume] | | |
| 10428-1 | Varicella zoster virus immune globulin given [Volume] | | |
| 10429-9 | AE 1 Ag [Presence] in Tissue by Immune stain | | |
| 1043-9 | H Ab [Presence] in Serum or Plasma from Donor | | |
| 10430-7 | AE 3 Ag [Presence] in Tissue by Immune stain | | |
| 10431-5 | B-cell Ag [Presence] in Tissue by Immune stain | | |
| 10432-3 | CD30 Ag [Presence] in Tissue by Immune stain | | |
| 10433-1 | BR-2 Ag [Presence] in Tissue by Immune stain | | |
| 10434-9 | Complement C3 Ag [Presence] in Tissue by Immune stain | | |
| 10435-6 | C5B-9 Ag [Presence] in Tissue by Immune stain | | |
| 10436-4 | CD15 Ag [Presence] in Tissue by Immune stain | | |
| 10437-2 | CD16 Ag [Presence] in Tissue by Immune stain | | |
| 10438-0 | CD20 Ag [Presence] in Tissue by Immune stain | | |
| 10439-8 | CD3 Ag [Presence] in Tissue by Immune stain | | |
| 1044-7 | H Ab [Presence] in Serum | | |
| 10440-6 | Deprecated CD30 Ag [Presence] in Tissue by Immune stain | | |
| 10441-4 | CD34 Ag [Presence] in Tissue by Immune stain | | |
| 10442-2 | CD56 Ag [Presence] in Tissue by Immune stain | | |
| 10443-0 | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain | | |
| 10444-8 | CD57 Ag [Presence] in Tissue by Immune stain | | |
| 10445-5 | CD11c Ag [Presence] in Tissue by Immune stain | | |
| 10446-3 | Leukocyte common Ag [Presence] in Tissue by Immune stain | | |
| 10447-1 | M-5 Ag [Presence] in Tissue by Immune stain | | |
| 10448-9 | T-cell Ag [Presence] in Tissue by Immune stain | | |
| 10449-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal | | |
| 1045-4 | Deprecated H NOS Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 10450-5 | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting | | |
| 10451-3 | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting | | |
| 10452-1 | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO | | |
| 10453-9 | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO | | |
| 10454-7 | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO | | |
| 10455-4 | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO | | |
| 10456-2 | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting | | |
| 10457-0 | Actin Ag [Presence] in Tissue by Immune stain | | |
| 10458-8 | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain | | |
| 10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain | | |
| 1046-2 | Deprecated H NOS Ab [Presence] in Serum or Plasma from Donor | | |
| 10460-4 | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain | | |
| 10461-2 | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain | | |
| 10462-0 | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain | | |
| 10463-8 | Amyloid A component Ag [Presence] in Tissue by Immune stain | | |
| 10464-6 | Amyloid P component Ag [Presence] in Tissue by Immune stain | | |
| 10465-3 | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain | | |
| 10466-1 | Anion gap 3 in Serum or Plasma | | |
| 10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain | | |
| 10468-7 | Calcitonin Ag [Presence] in Tissue by Immune stain | | |
| 10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain | | |
| 1047-0 | Deprecated H NOS Ab [Presence] in Serum or Plasma | | |
| 10470-3 | Choriogonadotropin Ag [Presence] in Tissue by Immune stain | | |
| 10471-1 | Chromogranin A Ag [Presence] in Tissue by Immune stain | | |
| 10472-9 | Chromogranin Ag [Presence] in Tissue by Immune stain | | |
| 10473-7 | Chymotrypsin Ag [Presence] in Tissue by Immune stain | | |
| 10474-5 | Collagen type 4 Ag [Presence] in Tissue by Immune stain | | |
| 10475-2 | Corticotropin Ag [Presence] in Tissue by Immune stain | | |
| 10476-0 | Desmin Ag [Presence] in Tissue by Immune stain | | |
| 10477-8 | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain | | |
| 10478-6 | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain | | |
| 10479-4 | CD227 Ag [Presence] in Tissue by Immune stain | | |
| 1048-8 | Deprecated H NOS Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain | | |
| 10481-0 | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain | | |
| 10482-8 | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain | | |
| 10483-6 | Gastrin Ag [Presence] in Tissue by Immune stain | | |
| 10484-4 | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain | | |
| 10485-1 | Glucagon Ag [Presence] in Tissue by Immune stain | | |
| 10486-9 | Hemoglobin Ag [Presence] in Tissue by Immune stain | | |
| 10487-7 | HMB-45 Ag [Presence] in Tissue by Immune stain | | |
| 10488-5 | IgA Ag [Presence] in Tissue by Immune stain | | |
| 10489-3 | IgA.heavy chain Ag [Presence] in Tissue by Immune stain | | |
| 1049-6 | Deprecated H NOS Ag [Presence] on Red Blood Cells from Donor | | |
| 10490-1 | IgE Ag [Presence] in Tissue by Immune stain | | |
| 10491-9 | IgG Ag [Presence] in Tissue by Immune stain | | |
| 10492-7 | IgG.heavy chain Ag [Presence] in Tissue by Immune stain | | |
| 10493-5 | IgM Ag [Presence] in Tissue by Immune stain | | |
| 10494-3 | IgM.heavy chain Ag [Presence] in Tissue by Immune stain | | |
| 10495-0 | Insulin Ag [Presence] in Tissue by Immune stain | | |
| 10496-8 | Kappa light chains Ag [Presence] in Tissue by Immune stain | | |
| 10497-6 | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain | | |
| 10498-4 | Keratin Ag [Presence] in Tissue by Immune stain | | |
| 10499-2 | Lambda light chains Ag [Presence] in Tissue by Immune stain | | |
| 105-7 | Ceforanide [Susceptibility] by Disk diffusion (KB) | | |
| 1050-4 | Deprecated H NOS Ag [Presence] on Red Blood Cells | | |
| 10500-7 | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain | | |
| 10501-5 | Lutropin [Units/volume] in Serum or Plasma | | |
| 10502-3 | Lutropin Ag [Presence] in Tissue by Immune stain | | |
| 10503-1 | Lysozyme Ag [Presence] in Tissue by Immune stain | | |
| 10504-9 | Myelin basic protein Ag [Presence] in Tissue by Immune stain | | |
| 10505-6 | Myoglobin Ag [Presence] in Tissue by Immune stain | | |
| 10506-4 | Peanut agglutinin Ag [Presence] in Tissue by Immune stain | | |
| 10507-2 | Prolactin Ag [Presence] in Tissue by Immune stain | | |
| 10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain | | |
| 10509-8 | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain | | |
| 1051-2 | Hemolytic disease of newborn screen [Interpretation] in Blood | | |
| 10510-6 | S-100 Ag [Presence] in Tissue by Immune stain | | |
| 10511-4 | Serotonin Ag [Presence] in Tissue by Immune stain | | |
| 10512-2 | Somatostatin Ag [Presence] in Tissue by Immune stain | | |
| 10513-0 | Somatotropin Ag [Presence] in Tissue by Immune stain | | |
| 10514-8 | Synaptophysin Ag [Presence] in Tissue by Immune stain | | |
| 10515-5 | Thyroglobulin Ag [Presence] in Tissue by Immune stain | | |
| 10516-3 | Thyrotropin Ag [Presence] in Tissue by Immune stain | | |
| 10517-1 | Trypsin Ag [Presence] in Tissue by Immune stain | | |
| 10518-9 | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain | | |
| 10519-7 | Vimentin Ag [Presence] in Tissue by Immune stain | | |
| 1052-0 | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit | | |
| 10520-5 | Coagulation factor VI Ag [Presence] in Tissue by Immune stain | | |
| 10521-3 | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain | | |
| 10522-1 | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain | | |
| 10523-9 | Fibrinogen Ag [Presence] in Tissue by Immune stain | | |
| 10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain | | |
| 10525-4 | Microscopic observation [Identifier] in Specimen by Cyto stain | | |
| 10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain | | |
| 10527-0 | Microscopic observation [Identifier] in Tissue by Cyto stain | | |
| 10528-8 | Acetophenazine [Mass/volume] in Serum or Plasma | | |
| 10529-6 | Amoxapine metabolite [Mass/volume] in Serum or Plasma | | |
| 1053-8 | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor | | |
| 10530-4 | Aprobarbital [Mass/volume] in Serum or Plasma | | |
| 10531-2 | Bretylium [Mass/volume] in Serum or Plasma | | |
| 10532-0 | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma | | |
| 10533-8 | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma | | |
| 10534-6 | Diazoxide [Mass/volume] in Serum or Plasma | | |
| 10535-3 | Digoxin [Mass/volume] in Serum or Plasma | | |
| 10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma | | |
| 10537-9 | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma | | |
| 10538-7 | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | | |
| 10539-5 | glipiZIDE [Mass/volume] in Serum or Plasma | | |
| 1054-6 | Deprecated I (intermediate) subtype [Presence] in srum | | |
| 10540-3 | glyBURIDE [Mass/volume] in Serum or Plasma | | |
| 10541-1 | Mepivacaine [Mass/volume] in Serum or Plasma | | |
| 10542-9 | Metharbital [Mass/volume] in Serum or Plasma | | |
| 10543-7 | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma | | |
| 10544-5 | Normeperidine [Presence] in Serum or Plasma | | |
| 10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma | | |
| 10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma | | |
| 10547-8 | Primidone+PHENobarbital [Mass/volume] in Serum or Plasma | | |
| 10548-6 | Phenytoin Free/Phenytoin.total in Serum or Plasma | | |
| 10549-4 | Pirmenol [Mass/volume] in Serum or Plasma | | |
| 1055-3 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit | | |
| 10550-2 | Deprecated Temazepam [Mass/volume] in Serum or Plasma | | |
| 10551-0 | Triamterene [Mass/volume] in Serum or Plasma | | |
| 10552-8 | Tricyclic antidepressants [Mass/volume] in Serum or Plasma | | |
| 10553-6 | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid | | |
| 10554-4 | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma | | |
| 10555-1 | Acrosin [Entitic Catalytic Activity] in Spermatozoa | | |
| 10556-9 | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma | | |
| 10557-7 | Adenosine triphosphate [Moles/volume] in Semen | | |
| 10558-5 | Albumin [Moles/volume] in Semen | | |
| 10559-3 | Deprecated Calcium [Molecules/volume] in Semen | | |
| 1056-1 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor | | |
| 10560-1 | Carcinoembryonic Ag [Units/volume] in Semen | | |
| 10561-9 | Carnitine [Moles/volume] in Semen | | |
| 10562-7 | Cells [#/volume] in Cervical mucus | | |
| 10563-5 | Cells other than spermatozoa [#/volume] in Semen | | |
| 10564-3 | Cervical mucus [Volume] | | |
| 10565-0 | Choriogonadotropin [Units/volume] in Semen | | |
| 10566-8 | Deprecated Choriogonadotropin [Molecules/volume] in Semen | | |
| 10567-6 | Citrate [Moles/volume] in Semen | | |
| 10568-4 | Clarity of Semen | | |
| 10569-2 | Color of Semen | | |
| 1057-9 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells | | |
| 10570-0 | Consistency of Cervical mucus | | |
| 10571-8 | Deprecated Consistency of Semen | | |
| 10572-6 | Deprecated Duration^post ejaculation | | |
| 10573-4 | Ferning [Type] in Cervical mucus | | |
| 10574-2 | Fructose [Moles/volume] in Semen | | |
| 10575-9 | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen | | |
| 10576-7 | Germ cells.immature [#/volume] in Semen | | |
| 10577-5 | Glucosidase [Enzymatic activity/volume] in Seminal plasma | | |
| 10578-3 | Glycerophosphocholine [Moles/volume] in Seminal plasma | | |
| 10579-1 | Leukocytes [#/volume] in Semen | | |
| 1058-7 | I Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 10580-9 | Liquefaction [Time] in Semen | | |
| 10581-7 | Deprecated Number of entities [#] in Spermatozoa | | |
| 10582-5 | pH of Cervical mucus | | |
| 10583-3 | Prostaglandin F1 alpha [Moles/volume] in Semen | | |
| 10584-1 | Deprecated Protein [Mass/volume] in Semen | | |
| 10585-8 | Round cells [#/volume] in Semen | | |
| 10586-6 | Deprecated Volume of Semen | | |
| 10587-4 | Sexual abstinence duration | | |
| 10588-2 | Spermatogonia [#/volume] in Semen | | |
| 10589-0 | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) | | |
| 1059-5 | I Ab [Presence] in Serum or Plasma from Donor | | |
| 10590-8 | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) | | |
| 10591-6 | Primary Spermatocytes [#/volume] in Semen | | |
| 10592-4 | Secondary Spermatocytes [#/volume] in Semen | | |
| 10593-2 | Spermatozoa Pyriform Head/100 spermatozoa in Semen | | |
| 10594-0 | Spermatozoa Tapering Head/100 spermatozoa in Semen | | |
| 10595-7 | Deprecated Spermatozoa [#/volume] in Semen | | |
| 10596-5 | Deprecated Spermatozoa Ab in cervical mucosa | | |
| 10597-3 | Deprecated Spermatozoa Ab in semen | | |
| 10598-1 | Deprecated Spermatozoa Ab in serum | | |
| 10599-9 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test | | |
| 106-5 | Ceforanide [Susceptibility] by Serum bactericidal titer | | |
| 1060-3 | I Ab [Presence] in Serum or Plasma | | |
| 10600-5 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa | | |
| 10601-3 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus | | |
| 10602-1 | Spermatozoa Abnormal Head/100 spermatozoa in Semen | | |
| 10603-9 | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen | | |
| 10604-7 | Spermatozoa Abnormal Tail/100 spermatozoa in Semen | | |
| 10605-4 | Spermatozoa Agglutinated/100 spermatozoa in Semen | | |
| 10606-2 | Spermatozoa Amorphous Head/100 spermatozoa in Semen | | |
| 10607-0 | Spermatozoa Coiled Tail/100 spermatozoa in Semen | | |
| 10608-8 | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen | | |
| 10609-6 | Spermatozoa Duplicate Head/100 spermatozoa in Semen | | |
| 1061-1 | Deprecated I NOS Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 10610-4 | Spermatozoa Duplicate Tail/100 spermatozoa in Semen | | |
| 10611-2 | Spermatozoa Immotile/100 spermatozoa in Semen | | |
| 10612-0 | Spermatozoa Large Oval Head/100 spermatozoa in Semen | | |
| 10613-8 | Spermatozoa Viable/100 spermatozoa in Semen | | |
| 10614-6 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead | | |
| 10615-3 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction | | |
| 10616-1 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead | | |
| 10617-9 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction | | |
| 10618-7 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead | | |
| 10619-5 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction | | |
| 1062-9 | Deprecated I NOS Ab [Presence] in Serum or Plasma from Donor | | |
| 10620-3 | Spermatozoa Nonprogressive/100 spermatozoa in Semen | | |
| 10621-1 | Spermatozoa Normal Head/100 spermatozoa in Semen | | |
| 10622-9 | Spermatozoa Normal/100 spermatozoa in Semen | | |
| 10623-7 | Spermatozoa Pin Head/100 spermatozoa in Semen | | |
| 10624-5 | Spermatozoa Rapid/100 spermatozoa in Semen | | |
| 10625-2 | Spermatozoa Round Head/100 spermatozoa in Semen | | |
| 10626-0 | Spermatozoa Slow/100 spermatozoa in Semen | | |
| 10627-8 | Spermatozoa Small Oval Head/100 spermatozoa in Semen | | |
| 10628-6 | Spermatozoa Tail Swelling/100 spermatozoa in Semen | | |
| 10629-4 | Spermatozoa Vacuolated Head/100 spermatozoa in Semen | | |
| 1063-7 | Deprecated I NOS Ab [Presence] in Serum or Plasma | | |
| 10630-2 | Spinnbarkeit [Length] in Cervical mucus | | |
| 10631-0 | Testosterone [Moles/volume] in Semen | | |
| 10632-8 | Time until next menstrual period | | |
| 10633-6 | Zinc [Moles/volume] in Semen | | |
| 10634-4 | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma | | |
| 10635-1 | Acanthamoeba sp identified in Eye by Organism specific culture | | |
| 10636-9 | Acanthamoeba sp identified in Eye by Wet preparation | | |
| 10637-7 | Microscopic observation [Identifier] in Tissue by Night blue stain | | |
| 10638-5 | Thermophilic Actinomycetes colony count [#/volume] in Specimen by Organism specific culture | | |
| 10639-3 | Thermophilic Actinomycetes identified in Specimen by Organism specific culture | | |
| 1064-5 | Deprecated I NOS Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 10640-1 | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy | | |
| 10641-9 | Amoeba identified in Aspirate by Immune stain | | |
| 10642-7 | Amoeba identified in Aspirate by Wet preparation | | |
| 10643-5 | Amoeba identified in Stool by Organism specific culture | | |
| 10644-3 | Arthropod identified in Specimen | | |
| 10645-0 | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence | | |
| 10646-8 | Astrovirus [Identifier] in Stool by Electron microscopy | | |
| 10647-6 | Babesia sp identified in Blood by Thick film | | |
| 10648-4 | Babesia sp identified in Blood by Thin film | | |
| 10649-2 | Calicivirus [Identifier] in Stool by Electron microscopy | | |
| 1065-2 | Deprecated I NOS Ag [Presence] on Red Blood Cells from Donor | | |
| 10650-0 | Candida sp DNA [Presence] in Blood by Probe with amplification | | |
| 10651-8 | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial | | |
| 10652-6 | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification | | |
| 10653-4 | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
| 10654-2 | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) | | |
| 10655-9 | Coccidia identified in Duodenal fluid by Acid fast stain | | |
| 10656-7 | Coccidia identified in Stool by Acid fast stain | | |
| 10657-5 | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence | | |
| 10658-3 | Cyanobacterium identified in Water by Light microscopy | | |
| 10659-1 | Cyclospora sp identified in Stool by Acid fast stain | | |
| 1066-0 | Deprecated I NOS Ag [Presence] on Red Blood Cells | | |
| 10660-9 | Cytomegalovirus Ag [Presence] in Tissue by Immune stain | | |
| 10661-7 | Dinoflagellate identified in Water by Light microscopy | | |
| 10662-5 | Filaria identified in Blood by Concentration | | |
| 10663-3 | Filaria identified in Blood by Thick film | | |
| 10664-1 | Filaria identified in Blood by Thin film | | |
| 10665-8 | Fungus colony count [#/volume] in Specimen by Environmental culture | | |
| 10666-6 | Fungus identified in Tissue by Fontana-Masson stain | | |
| 10667-4 | Fungus identified in Specimen by Animal inoculation | | |
| 10668-2 | Fungus identified in Specimen by Environmental culture | | |
| 10669-0 | Fungus identified in Specimen by Sticky tape for environmental fungus | | |
| 1067-8 | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 10670-8 | Giardia lamblia [Presence] in Stool by Organism specific culture | | |
| 10671-6 | Helminth identified in Specimen | | |
| 10672-4 | Helminth+Arthropod identified in Specimen | | |
| 10673-2 | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain | | |
| 10674-0 | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain | | |
| 10675-7 | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain | | |
| 10676-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | | |
| 10677-3 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain | | |
| 10678-1 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain | | |
| 10679-9 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain | | |
| 1068-6 | Jk sup(a) Ab [Presence] in Serum or Plasma from Donor | | |
| 10680-7 | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy | | |
| 10681-5 | Herpes simplex virus identified in Tissue by Electron microscopy | | |
| 10682-3 | Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification | | |
| 10683-1 | Hydatid cyst identified in Aspirate by Immune stain | | |
| 10684-9 | Hydatid cyst identified in Liver by Wet preparation | | |
| 10685-6 | Hydatid cyst identified in Lung tissue by Wet preparation | | |
| 10686-4 | Leishmania sp identified in Tissue by Giemsa stain | | |
| 10687-2 | Leishmania sp identified in Tissue by Organism specific culture | | |
| 10688-0 | Microscopic observation [Identifier] in Hair by KOH preparation | | |
| 10689-8 | Microscopic observation [Identifier] in Nail by KOH preparation | | |
| 1069-4 | Jk sup(a) Ab [Presence] in Serum or Plasma | | |
| 10690-6 | Microsporidia identified in Duodenal fluid by Trichrome stain modified | | |
| 10691-4 | Mushroom.toxic identified by Inspection | | |
| 10692-2 | Mushroom.toxic identified in Food by Light microscopy | | |
| 10693-0 | Mushroom.toxic identified in Vomitus by Light microscopy | | |
| 10694-8 | Naegleria sp identified in Tissue by Organism specific culture | | |
| 10695-5 | Naegleria sp identified in Tissue by Wet preparation | | |
| 10696-3 | Norovirus [Identifier] in Stool by Electron microscopy | | |
| 10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
| 10698-9 | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) | | |
| 10699-7 | Onchocerca sp identified in Tissue by Wet preparation | | |
| 107-3 | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) | | |
| 1070-2 | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 10700-3 | Orthopoxvirus [Identifier] in Skin by Electron microscopy | | |
| 10701-1 | Ova and parasites identified in Stool by Concentration | | |
| 10702-9 | Ova and parasites identified in Stool by Immune stain | | |
| 10703-7 | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain | | |
| 10704-5 | Ova and parasites identified in Stool by Light microscopy | | |
| 10705-2 | Human papilloma virus Ag [Presence] in Tissue by Immune stain | | |
| 10706-0 | Picornavirus [Identifier] in Stool by Electron microscopy | | |
| 10707-8 | Toxic Plant identified in Plant specimen by Inspection | | |
| 10708-6 | Toxic Plant identified in Vomitus by Light microscopy | | |
| 10709-4 | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence | | |
| 1071-0 | Jk sup(a) Ag [Presence] on Red Blood Cells from Donor | | |
| 10710-2 | Plasmodium sp identified in Blood by Thin film | | |
| 10711-0 | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence | | |
| 10712-8 | Pneumocystis sp identified in Lung tissue | | |
| 10713-6 | Prototheca identified in Specimen by Culture | | |
| 10714-4 | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy | | |
| 10715-1 | Schistosoma sp identified in Urine sediment by Light microscopy | | |
| 10716-9 | Schistosoma sp identified in Specimen by Organism specific culture | | |
| 10717-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination | | |
| 10718-5 | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay | | |
| 10719-3 | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot | | |
| 1072-8 | Jk sup(a) Ag [Presence] on Red Blood Cells | | |
| 10720-1 | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
| 10721-9 | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) | | |
| 10722-7 | Torovirus [Identifier] in Stool by Electron microscopy | | |
| 10723-5 | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay | | |
| 10724-3 | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay | | |
| 10725-0 | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification | | |
| 10726-8 | Toxoplasma gondii [Presence] in Tissue by Giemsa stain | | |
| 10727-6 | Toxoplasma gondii identified in Tissue | | |
| 10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture | | |
| 10729-2 | Trypanosoma sp identified in Blood by Light microscopy | | |
| 1073-6 | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 10730-0 | Trypanosoma sp identified in Blood by Organism specific culture | | |
| 10731-8 | Trypanosoma sp identified in Blood by Thick film | | |
| 10732-6 | Trypanosoma sp identified in Blood by Thin film | | |
| 10733-4 | Trypanosoma sp identified in Blood by Wet preparation | | |
| 10734-2 | Varicella zoster virus identified in Skin by Electron microscopy | | |
| 10735-9 | Viral sequencing [Identifier] in Serum by Sequencing | | |
| 10736-7 | Virus identified in Cerebral spinal fluid by Electron microscopy | | |
| 10737-5 | Virus identified in Stool by Electron microscopy | | |
| 10738-3 | Virus identified in Tissue by Electron microscopy | | |
| 10739-1 | Virus identified in Specimen by Electron microscopy | | |
| 1074-4 | Jk sup(b) Ab [Presence] in Serum or Plasma from Donor | | |
| 10740-9 | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain | | |
| 10741-7 | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain | | |
| 10742-5 | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified | | |
| 10743-3 | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain | | |
| 10744-1 | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain | | |
| 10745-8 | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain | | |
| 10746-6 | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain | | |
| 10747-4 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain | | |
| 10748-2 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain | | |
| 10749-0 | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain | | |
| 1075-1 | Jk sup(b) Ab [Presence] in Serum or Plasma | | |
| 10750-8 | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson | | |
| 10751-6 | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain | | |
| 10752-4 | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain | | |
| 10753-2 | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain | | |
| 10754-0 | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain | | |
| 10755-7 | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott | | |
| 10756-5 | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain | | |
| 10757-3 | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald | | |
| 10758-1 | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain | | |
| 10759-9 | Iron.microscopic observation [Identifier] in Sputum by Gomori stain | | |
| 1076-9 | Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 10760-7 | Iron.microscopic observation [Identifier] in Tissue by Gomori stain | | |
| 10761-5 | Iron.microscopic observation [Identifier] in Tissue by Other stain | | |
| 10762-3 | Microscopic observation [Identifier] in Blood by Hemosiderin stain | | |
| 10763-1 | Microscopic observation [Identifier] in Body fluid by Sudan black stain | | |
| 10764-9 | Microscopic observation [Identifier] in Sputum by Silver stain | | |
| 10765-6 | Microscopic observation [Identifier] in Tissue by Acetate esterase stain | | |
| 10766-4 | Microscopic observation [Identifier] in Tissue by Alcian blue stain | | |
| 10767-2 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated | | |
| 10768-0 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff | | |
| 10769-8 | Microscopic observation [Identifier] in Tissue by Alizarin red S stain | | |
| 1077-7 | Jk sup(b) Ag [Presence] on Red Blood Cells from Donor | | |
| 10770-6 | Microscopic observation [Identifier] in Tissue by Argentaffin stain | | |
| 10771-4 | Deprecated Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain | | |
| 10772-2 | Microscopic observation [Identifier] in Tissue by Azure-eosin stain | | |
| 10773-0 | Microscopic observation [Identifier] in Tissue by Basic fuchsin stain | | |
| 10774-8 | Microscopic observation [Identifier] in Tissue by Bielschowsky stain | | |
| 10775-5 | Microscopic observation [Identifier] in Tissue by Bleach stain | | |
| 10776-3 | Microscopic observation [Identifier] in Tissue by Bodian stain | | |
| 10777-1 | Microscopic observation [Identifier] in Tissue by Brown and Brenn stain | | |
| 10778-9 | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain | | |
| 10779-7 | Microscopic observation [Identifier] in Tissue by Carmine stain.Best | | |
| 1078-5 | Jk sup(b) Ag [Presence] on Red Blood Cells | | |
| 10780-5 | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain | | |
| 10781-3 | Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain | | |
| 10782-1 | Microscopic observation [Identifier] in Tissue by Congo red stain | | |
| 10783-9 | Microscopic observation [Identifier] in Tissue by Crystal violet stain | | |
| 10784-7 | Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific | | |
| 10785-4 | Microscopic observation [Identifier] in Tissue by Fite-Faraco stain | | |
| 10786-2 | Deprecated Microscopic observation [Identifier] in Tissue by Giemsa stain.3 micron | | |
| 10787-0 | Microscopic observation [Identifier] in Tissue by Gridley stain | | |
| 10788-8 | Microscopic observation [Identifier] in Tissue by Hansel stain | | |
| 10789-6 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain | | |
| 1079-3 | Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | | |
| 10790-4 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain | | |
| 10791-2 | Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain | | |
| 10792-0 | Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones | | |
| 10793-8 | Microscopic observation [Identifier] in Tissue by Methyl green stain | | |
| 10794-6 | Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain | | |
| 10795-3 | Microscopic observation [Identifier] in Tissue by Methyl violet stain | | |
| 10796-1 | Microscopic observation [Identifier] in Tissue by Mucicarmine stain | | |
| 10797-9 | Microscopic observation [Identifier] in Tissue by Neutral red stain | | |
| 10798-7 | Microscopic observation [Identifier] in Tissue by Oil red O stain | | |
| 10799-5 | Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat | | |
| 108-1 | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
| 1080-1 | Js sup(a) Ab [Presence] in Serum or Plasma from Donor | | |
| 10800-1 | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion | | |
| 10801-9 | Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain | | |
| 10802-7 | Microscopic observation [Identifier] in Tissue by Prussian blue stain | | |
| 10803-5 | Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain | | |
| 10804-3 | Microscopic observation [Identifier] in Tissue by Reticulin stain | | |
| 10805-0 | Microscopic observation [Identifier] in Tissue by Safranin stain | | |
| 10806-8 | Microscopic observation [Identifier] in Tissue by Schmorl stain | | |
| 10807-6 | Microscopic observation [Identifier] in Tissue by Sevier-Munger stain | | |
| 10808-4 | Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle | | |
| 10809-2 | Microscopic observation [Identifier] in Tissue by Silver nitrate stain | | |
| 1081-9 | Js sup(a) Ab [Presence] in Serum or Plasma | | |
| 10810-0 | Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson | | |
| 10811-8 | Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius | | |
| 10812-6 | Microscopic observation [Identifier] in Tissue by Steiner stain | | |
| 10813-4 | Microscopic observation [Identifier] in Tissue by Sudan black stain | | |
| 10814-2 | Microscopic observation [Identifier] in Tissue by Supravital stain | | |
| 10815-9 | Microscopic observation [Identifier] in Tissue by Tetrachrome stain | | |
| 10816-7 | Deprecated Microscopic observation [Identifier] in Tissue by Toluidine blue O stain | | |
| 10817-5 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley | | |
| 10818-3 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified | | |
| 10819-1 | Microscopic observation [Identifier] in Tissue by Wade stain | | |
| 1082-7 | Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | | |
| 10820-9 | Deprecated Microscopic observation [Identifier] in Tissue by Warthin-Starry stain | | |
| 10821-7 | Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain | | |
| 10822-5 | Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer | | |
| 10823-3 | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale | | |
| 10824-1 | Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain | | |
| 10825-8 | Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain | | |
| 10826-6 | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain | | |
| 10827-4 | Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain | | |
| 10828-2 | Urate crystals.microscopic observation [type] in Tissue by De Galantha stain | | |
| 10829-0 | Silicon [Mass/volume] in Serum or Plasma | | |
| 100002-5 | | Specimen care is maintained | |
| 100003-3 | | Team communication is maintained throughout care | |
| 100004-1 | | Demonstrates knowledge of the expected psychosocial responses to the procedure | |
| 100005-8 | | Demonstrates knowledge of nutritional management related to the procedure | |
| 100006-6 | | Demonstrates knowledge of medication management | |
| 100007-4 | | Demonstrates knowledge of pain management | |
| 100008-2 | | Demonstrates knowledge of wound management | |
| 100009-0 | | Demonstrates knowledge of the procedure and expected results | |
| 100010-8 | | No injury related to procedure equipment, medical supplies, or instrumentation | |
| 100011-6 | | No injury related to an electrical source | |
| 100012-4 | | Participates in decisions affecting the patient's plan of care | |
| 100013-2 | | Participates in the discharge process | |
| 100014-0 | | Psychosocial health is maintained at or improved from baseline | |
| 100015-7 | | No injury related to positioning due to care or procedure | |
| 100016-5 | | No injury related to a laser source | |
| 100017-3 | | Perioperative nursing data set outcomes panel [PNDS] | |
| 100030-6 | | Axis I: Temporal aspects score [Mainz Pain Staging System] | |
| 100031-4 | | Axis II: Spatial aspects score [Mainz Pain Staging System] | |
| 100032-2 | | Axis III: Drug taking behavior score [Mainz Pain Staging System] | |
| 100033-0 | | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | |
| 100159-3 | | Knee Society Score pre-op panel [Knee Society Score] | |
| 100168-4 | | Knee pain severity with level walking | |
| 100169-2 | | Knee pain severity with stairs or inclines | |
| 100170-0 | | Knee feels normal | |
| 100171-8 | | Satisfaction with level of knee pain while sitting | |
| 100172-6 | | Satisfaction with level of knee pain while lying in bed | |
| 100173-4 | | Satisfaction with knee function while getting out of bed | |
| 100174-2 | | Satisfaction with knee function while performing light household duties | |
| 100175-9 | | Satisfaction with knee function while performing recreational activities | |
| 100176-7 | | Expect surgery to relieve pain | |
| 100177-5 | | Expect surgery will improve ability to perform activities of daily living | |
| 100178-3 | | Expect surgery will improve ability to perform leisure, recreational, or sports activities | |
| 100179-1 | | Walk without assistive mobility devices | |
| 100180-9 | | Assistive mobility devices used | |
| 100181-7 | | Assistive mobility devices used due to health condition | |
| 100182-5 | | Duration of standing before sitting due to knee discomfort | |
| 100183-3 | | Duration of walking before stopping due to knee discomfort | |
| 100184-1 | | How bothersome is knee when walking on an uneven surface | |
| 100185-8 | | How bothersome is knee when turning or pivoting leg | |
| 100186-6 | | How bothersome is knee when climbing up or down a flight of stairs | |
| 100187-4 | | How bothersome is knee when getting up from a low seat without armrests | |
| 100188-2 | | How bothersome is knee when getting into or out of a car | |
| 100189-0 | | How bothersome is knee when moving laterally | |
| 100190-8 | | How bothersome is knee when climbing a ladder or step stool | |
| 100191-6 | | How bothersome is knee when carrying a bag for one block | |
| 100192-4 | | How bothersome is knee when squatting | |
| 100193-2 | | How bothersome is knee when kneeling | |
| 100194-0 | | How bothersome is knee when running | |
| 100195-7 | | Pain severity--during activity | |
| 100196-5 | | Pre-op total score [Knee Society Score] | |
| 100197-3 | | Exercise activity and pain severity panel | |
| 100198-1 | | Pre-op objective knee indicators score [Knee Society Score] | |
| 100199-9 | | Pre-op symptoms score [Knee Society Score] | |
| 100200-5 | | Pre-op patient expectations score [Knee Society Score] | |
| 100201-3 | | Pre-op functional activities score [Knee Society Score] | |
| 100202-1 | | Pre-op discretionary knee activities score [Knee Society Score] | |
| 100203-9 | | Knee Society Score post-op panel [Knee Society Score] | |
| 100204-7 | | Accuracy of pre-surgery expectations of pain relief | |
| 100205-4 | | Accuracy of pre-surgery expectations to perform activities of daily living | |
| 100206-2 | | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities | |
| 100207-0 | | Post-op total score [Knee Society Score] | |
| 100208-8 | | Post-op objective knee indicators score [Knee Society Score] | |
| 100209-6 | | Post-op symptoms score [Knee Society Score] | |
| 100210-4 | | Post-op patient expectations score [Knee Society Score] | |
| 100211-2 | | Post-op functional activities score [Knee Society Score] | |
| 100212-0 | | Post-op discretionary knee activities score [Knee Society Score] | |
| 100232-8 | | Impacts of Events Scale-Revised panel | |
| 100233-6 | | Reminders brought back feelings about adverse event | |
| 100234-4 | | Trouble staying asleep | |
| 100235-1 | | Other things triggered persistent thoughts about adverse event | |
| 100236-9 | | Felt irritable AndOr angry | |
| 100237-7 | | Avoided getting upset when unintentionally thought about adverse event | |
| 100238-5 | | Thought about adverse event unintentionally | |
| 100239-3 | | Felt as if adverse event did not happen | |
| 100240-1 | | Avoided reminders of adverse event | |
| 100241-9 | | Experienced mental images of adverse event | |
| 100242-7 | | Easily startled | |
| 100243-5 | | Tried to not think of adverse event | |
| 100244-3 | | Aware of feelings about adverse event, but did not address them | |
| 100245-0 | | Feelings about adverse event were numb | |
| 100246-8 | | Acted or felt the same as during adverse event | |
| 100247-6 | | Trouble falling asleep | |
| 100248-4 | | Waves of strong feelings about adverse event | |
| 100249-2 | | Tried to remove adverse event from memory | |
| 100250-0 | | Trouble concentrating | |
| 100251-8 | | Reminders of adverse event caused physical reactions | |
| 100252-6 | | Had dreams about adverse event | |
| 100253-4 | | Felt watchful and on-guard | |
| 100254-2 | | Tried not to talk about adverse event | |
| 100255-9 | | Total score [Impact of Event Scale-Revised] | |
| 100259-1 | | Aware of tactile sensations | |
| 100260-9 | | Easy to describe thoughts AndOr feelings | |
| 100261-7 | | Critical of own thoughts AndOr feelings | |
| 100262-5 | | Able to notice distressing thoughts AndOr feelings without having to react | |
| 100263-3 | | Easily distracted | |
| 100264-1 | | Able to notice thoughts AndOr feelings without being overwhelmed | |
| 100265-8 | | Aware of dietary intake impact on self | |
| 100266-6 | | Difficult to describe thoughts AndOr feelings | |
| 100267-4 | | Aware of auditory stimuli | |
| 100268-2 | | Able to avoid immediate reaction in difficult situations | |
| 100269-0 | | Do things without paying attention | |
| 100270-8 | | Recover quickly from distressing thoughts AndOr images | |
| 100271-6 | | Aware of olfactory stimuli | |
| 100272-4 | | Aware of visual stimuli | |
| 100273-2 | | Aware of emotions affect on thoughts AndOr behavior | |
| 100274-0 | | Observing score [FFMQ] | |
| 100275-7 | | Describing score [FFMQ] | |
| 100276-5 | | Acting with awareness score [FFMQ] | |
| 100277-3 | | Nonjudging score [FFMQ] | |
| 100278-1 | | Nonreactivity score [FFMQ] | |
| 100279-9 | | Total score [FFMQ] | |
| 100280-7 | | Five Facet Mindfulness Questionnaire panel [FFMQ] | |
| 100283-1 | | Harris Hip Score panel [Harris Hip Score] | |
| 100284-9 | | Walking - functional ability | |
| 100285-6 | | Comfortable seated position | |
| 100286-4 | | Able to board public transportation | |
| 100287-2 | | Put on shoes and socks | |
| 100288-0 | | Absence of deformity score [Harris Hip Score] | |
| 100289-8 | | Absence of hip deformity measurements | |
| 100290-6 | | Range of motion score [Harris Hip Score] | |
| 100291-4 | | Total score [Harris Hip Score] | |
| 100292-2 | | Pre-op patient satisfaction score [Knee Society Score] | |
| 100293-0 | | Hip Flexion range of motion | |
| 100294-8 | | Hip Abduction range of motion | |
| 100295-5 | | Hip Adduction range of motion | |
| 100296-3 | | Hip External rotation range of motion | |
| 100297-1 | | Hip Internal rotation range of motion | |
| 100299-7 | | Post-op patient satisfaction score [Knee Society Score] | |
| 100307-8 | | Behavioral screening elder mistreatment | |
| 100308-6 | | Need help getting to essential places | |
| 100309-4 | | Activity support person | |
| 100310-2 | | Reliability of support person | |
| 100311-0 | | Need help to make sure there is enough food, medicines or any other things needed in house | |
| 100312-8 | | Person or persons that makes sure there is enough food, medicines or any other things needed in house | |
| 100313-6 | | Need help with household things such as cook meals, help feed, or provide correct medicines each day | |
| 100314-4 | | Need help with house cleaning or yard work | |
| 100315-1 | | Need help getting out of bed, showered, or dressed | |
| 100316-9 | | Need help to make sure bills get paid | |
| 100317-7 | | Relationship of usual support person for daily activities | |
| 100318-5 | | Have help with finances AndOr financial decisions | |
| 100319-3 | | Relationship of financial support person | |
| 100320-1 | | Financial support person usually asks for permission before making decisions | |
| 100321-9 | | Financial support person usually makes good decisions about finances | |
| 100322-7 | | Have access to paperwork for financial decisions made | |
| 100323-5 | | Financial support person forged signature | |
| 100324-3 | | Coercion of financial support person for signing a document in order to get money or possessions | |
| 100325-0 | | Experienced theft by support person | |
| 100326-8 | | Money spent or property sold without permission | |
| 100327-6 | | Stranger forged signature for financial gain | |
| 100328-4 | | Stranger forced document signature for financial gain | |
| 100329-2 | | Feared for safety due to verbal attack | |
| 100330-0 | | Felt humiliated due to ridicule | |
| 100331-8 | | Coerced to do something | |
| 100332-6 | | Ignored by close friend or relative for extended period | |
| 100333-4 | | Physically hit or threatened | |
| 100334-2 | | Been physically hurt with some degree of injury | |
| 100335-9 | | Coerced sexual activity | |
| 100336-7 | | Coerced touching of private body parts of self or others | |
| 100337-5 | | Coerced to undress or expose private body area | |
| 100338-3 | | Photographed in any degree of nudity without consent | |
| 100339-1 | | Experienced attempted physical restraint | |
| 100340-9 | | Range of motion panel Hip | |
| 100353-2 | | Norwalk Community Health Center Screening Tool [NCHC] | |
| 100354-0 | | Frequency of participating in multi-modal communication without assistance | |
| 100355-7 | | Frequency of participating in spoken language expression communication without assistance | |
| 100360-7 | | Brief Resilience Scale panel [BRS] | |
| 100361-5 | | Quickly recover from bad events | |
| 100362-3 | | Difficulty making it through stressful events | |
| 100363-1 | | Easily recover from a stressful event | |
| 100364-9 | | Difficulty recovering from bad events | |
| 100365-6 | | Easily recover from difficulties | |
| 100366-4 | | Lengthy recovery from setbacks | |
| 100367-2 | | Total Score BRS | |
| 100766-5 | | Center for Epidemiologic Studies Depression Scale panel [CES-D] | |
| 100767-3 | | Bothered by things that are not usually bothersome | |
| 100768-1 | | Poor appetite | |
| 100769-9 | | Unhappy even with help from my family or friends | |
| 100770-7 | | Feeling just as good as others | |
| 100771-5 | | Trouble focusing | |
| 100772-3 | | Feeling depressed | |
| 100773-1 | | Feeling everything is too much of an effort | |
| 100774-9 | | Feeling hopeful about the future | |
| 100775-6 | | Feeling life had been a failure | |
| 100776-4 | | Feeling fearful | |
| 100777-2 | | Restless sleep | |
| 100778-0 | | Feeling happy | |
| 100779-8 | | Quieter than usual | |
| 100780-6 | | Feeling lonely | |
| 100781-4 | | People were unfriendly | |
| 100782-2 | | Enjoying life | |
| 100783-0 | | Crying spells | |
| 100784-8 | | Feeling sad | |
| 100785-5 | | Feeling people dislike me | |
| 100786-3 | | Lack of energy | |
| 100787-1 | | Total Score CES-D | |
| 100916-6 | | User satisfaction score [R-Outcomes] | |
| 100917-4 | | Product of interest effectiveness | |
| 100918-2 | | Product of interest usability | |
| 100919-0 | | Access to help with product of interest | |
| 100920-8 | | Satisfied with product of interest | |
| 100921-6 | | User satisfaction panel [R-Outcomes] | |
| 100922-4 | | Privacy panel [R-Outcomes] | |
| 100923-2 | | Privacy score [R-Outcomes] | |
| 100924-0 | | Safe and secure healthcare data | |
| 100925-7 | | Healthcare data exchanged as needed | |
| 100926-5 | | Access to review healthcare data | |
| 100927-3 | | Satisfied with healthcare data use | |
| 100928-1 | | Digital confidence panel [R-Outcomes] | |
| 100929-9 | | Digital confidence score [R-Outcomes] | |
| 100930-7 | | Digital device use | |
| 100931-5 | | Friends use digital devices | |
| 100932-3 | | Access to help with digital devices | |
| 100933-1 | | Confident using digital devices | |
| 100934-9 | | Personal safety panel [R-Outcomes] | |
| 100935-6 | | Personal safety score [R-Outcomes] | |
| 100936-4 | | Feel safe at home | |
| 100937-2 | | Feel respected at home | |
| 100938-0 | | Feel safe outside home | |
| 100939-8 | | Feel respected outside home | |
| 100940-6 | | Neighbor relationships panel [R-Outcomes] | |
| 100941-4 | | Neighbor relationships score [R-Outcomes] | |
| 100942-2 | | Neighbors and I know each other | |
| 100943-0 | | Neighbors and I trust each other | |
| 100944-8 | | Neighbors and I share information | |
| 100945-5 | | Neighbors and I help each other | |
| 100946-3 | | Loneliness (ONS) score | |
| 100947-1 | | Frequency of having no one to talk to | |
| 100948-9 | | Frequency of feeling left out | |
| 100949-7 | | Frequency of feeling alone | |
| 100950-5 | | Frequency of feeling lonely | |
| 100951-3 | | Loneliness Office of National Statistics panel | |
| 100952-1 | | Product confidence panel [R-Outcomes] | |
| 100953-9 | | Product confidence score [R-Outcomes] | |
| 100954-7 | | Product of interest use | |
| 100955-4 | | Confident using product of interest | |
| 100956-2 | | Understand potential benefits of product of interest | |
| 100957-0 | | Understand potential problems of product of interest | |
| 100958-8 | | Digital readiness panel [R-Outcomes] | |
| 100959-6 | | Digital readiness score [R-Outcomes] | |
| 100960-4 | | New ideas are needed in field of work | |
| 100961-2 | | Follow new ideas in field of work | |
| 28079-2 | | Activities of daily living alteration [CCC] | |
| 28080-0 | | Activity alteration [CCC] | |
| 28081-8 | | Activity intolerance [CCC] | |
| 28082-6 | | Activity intolerance risk [CCC] | |
| 28083-4 | | Acute pain [CCC] | |
| 28084-2 | | Adjustment impairment [CCC] | |
| 28085-9 | | Airway clearance impairment [CCC] | |
| 28086-7 | | Decisional conflict [CCC] | |
| 28087-5 | | Defensive coping [CCC] | |
| 28088-3 | | Denial [CCC] | |
| 28089-1 | | Diarrhea [CCC] | |
| 28090-9 | | Disabled family coping Family [CCC] | |
| 28091-7 | | Disuse syndrome [CCC] | |
| 28092-5 | | Diversional activity deficit [CCC] | |
| 28093-3 | | Dressing/grooming deficit [CCC] | |
| 28094-1 | | Dying process [CCC] | |
| 28095-8 | | Dysfunctional grieving [CCC] | |
| 28096-6 | | Autonomic dysreflexia [CCC] | |
| 28097-4 | | Endocrine alteration [CCC] | |
| 28098-2 | | Family coping impairment Family [CCC] | |
| 28099-0 | | Family process alteration Family [CCC] | |
| 28100-6 | | Fatigue [CCC] | |
| 28101-4 | | Fear [CCC] | |
| 28102-2 | | Fecal impaction [CCC] | |
| 28103-0 | | Feeding deficit [CCC] | |
| 28104-8 | | Fluid volume alteration [CCC] | |
| 28105-5 | | Fluid volume deficit [CCC] | |
| 28106-3 | | Fluid volume deficit risk [CCC] | |
| 28107-1 | | Fluid volume excess [CCC] | |
| 28108-9 | | Fluid volume excess risk [CCC] | |
| 28109-7 | | Functional urinary incontinence [CCC] | |
| 28110-5 | | Gas exchange impairment [CCC] | |
| 28111-3 | | Gastrointestinal alteration [CCC] | |
| 28112-1 | | Grieving [CCC] | |
| 28113-9 | | Growth and development alteration [CCC] | |
| 28114-7 | | Gustatory alteration [CCC] | |
| 28115-4 | | Health maintenance alteration [CCC] | |
| 28116-2 | | Health-seeking behavior alteration [CCC] | |
| 28117-0 | | Home maintenance alteration [CCC] | |
| 28118-8 | | Hopelessness [CCC] | |
| 28119-6 | | Hypothermia [CCC] | |
| 28120-4 | | Hyperthermia [CCC] | |
| 28121-2 | | Immunologic alteration [CCC] | |
| 28122-0 | | Individual coping impairment [CCC] | |
| 28123-8 | | Infection risk [CCC] | |
| 28124-6 | | Infection [CCC] | |
| 28125-3 | | Injury risk [CCC] | |
| 28126-1 | | Instrumental activity of daily living (IADLS) alteration [CCC] | |
| 28127-9 | | Kinesthetic alteration [CCC] | |
| 28128-7 | | Knowledge deficit [CCC] | |
| 28129-5 | | Knowledge deficit of diagnostic test [CCC] | |
| 28130-3 | | Knowledge deficit of dietary regimen [CCC] | |
| 28131-1 | | Knowledge deficit of disease process [CCC] | |
| 28132-9 | | Knowledge deficit of fluid volume [CCC] | |
| 28133-7 | | Knowledge deficit of medication regimen [CCC] | |
| 28134-5 | | Anticipatory grieving [CCC] | |
| 28135-2 | | Anxiety [CCC] | |
| 28136-0 | | Aspiration risk [CCC] | |
| 28137-8 | | Auditory alteration [CCC] | |
| 28138-6 | | Bathing/hygiene deficit [CCC] | |
| 28139-4 | | Blood pressure alteration [CCC] | |
| 28140-2 | | Body image disturbance [CCC] | |
| 28141-0 | | Body nutrition deficit [CCC] | |
| 28142-8 | | Body nutrition deficit risk [CCC] | |
| 28143-6 | | Body nutrition excess [CCC] | |
| 28144-4 | | Body nutrition excess risk [CCC] | |
| 28145-1 | | Bowel elimination alteration [CCC] | |
| 28146-9 | | Bowel incontinence [CCC] | |
| 28147-7 | | Breastfeeding impairment [CCC] | |
| 28148-5 | | Breathing pattern impairment [CCC] | |
| 28149-3 | | Cardiac output alteration [CCC] | |
| 28150-1 | | Cardiovascular alteration [CCC] | |
| 28151-9 | | Cerebral alteration [CCC] | |
| 28152-7 | | Chronic low self-esteem disturbance [CCC] | |
| 28153-5 | | Chronic pain [CCC] | |
| 28154-3 | | Colonic constipation [CCC] | |
| 28155-0 | | Comfort alteration [CCC] | |
| 28156-8 | | Communication impairment [CCC] | |
| 28157-6 | | Compromised family coping Family [CCC] | |
| 28158-4 | | May choose to self-deliver at the end [Living with HIV] | |
| 28159-2 | | Meaningful life [Living with HIV] | |
| 28160-0 | | Medications are taking over my life [Living with HIV] | |
| 28161-8 | | Need help letting go [Living with HIV] | |
| 28162-6 | | No energy to fight back [Living with HIV] | |
| 28163-4 | | Not enjoying life [Living with HIV] | |
| 28164-2 | | Pain is hard to manage [Living with HIV] | |
| 28165-9 | | So many things yet undone [Living with HIV] | |
| 28166-7 | | Somewhat disconnected [Living with HIV] | |
| 28167-5 | | Stay at home and receive treatment [Living with HIV] | |
| 28168-3 | | Take time for important things [Living with HIV] | |
| 28169-1 | | Use time wisely [Living with HIV] | |
| 28170-9 | | Want to die at home [Living with HIV] | |
| 28171-7 | | Knowledge deficit of safety precautions [CCC] | |
| 28172-5 | | Knowledge deficit of therapeutic regimen [CCC] | |
| 28173-3 | | Meaningfulness alteration [CCC] | |
| 28174-1 | | Medication risk [CCC] | |
| 28175-8 | | Musculoskeletal alteration [CCC] | |
| 28176-6 | | Noncompliance [CCC] | |
| 28177-4 | | Noncompliance with diagnostic test [CCC] | |
| 28178-2 | | Noncompliance with dietary regimen [CCC] | |
| 28179-0 | | Noncompliance with safety precautions [CCC] | |
| 28180-8 | | Noncompliance with therapeutic regimen [CCC] | |
| 28181-6 | | Nutrition alteration [CCC] | |
| 28182-4 | | Olfactory alteration [CCC] | |
| 28183-2 | | Oral mucous membranes impairment [CCC] | |
| 28184-0 | | Parental role conflict [CCC] | |
| 28185-7 | | Parenting alteration [CCC] | |
| 28186-5 | | Perceived constipation [CCC] | |
| 28187-3 | | Peripheral alteration [CCC] | |
| 28188-1 | | Personal identity disturbance [CCC] | |
| 28189-9 | | Physical mobility impairment [CCC] | |
| 28190-7 | | Physical regulation alteration [CCC] | |
| 28191-5 | | Poisoning risk [CCC] | |
| 28192-3 | | Polypharmacy [CCC] | |
| 28193-1 | | Post-trauma response [CCC] | |
| 28194-9 | | Powerlessness [CCC] | |
| 28195-6 | | Protection alteration [CCC] | |
| 28196-4 | | Rape trauma syndrome [CCC] | |
| 28197-2 | | Reflex urinary incontinence [CCC] | |
| 28198-0 | | Renal alteration [CCC] | |
| 28199-8 | | Respiration alteration [CCC] | |
| 28200-4 | | Role performance alteration [CCC] | |
| 28201-2 | | Self-care deficit [CCC] | |
| 28202-0 | | Self-concept alteration [CCC] | |
| 28203-8 | | Sensory perceptual alteration [CCC] | |
| 28204-6 | | Sexual dysfunction [CCC] | |
| 28205-3 | | Sexuality patterns alteration [CCC] | |
| 28206-1 | | Situational self-esteem disturbance [CCC] | |
| 28207-9 | | Skin incision [CCC] | |
| 28208-7 | | Skin integrity impairment [CCC] | |
| 28209-5 | | Skin integrity impairment risk [CCC] | |
| 28210-3 | | Sleep pattern disturbance [CCC] | |
| 28211-1 | | Social interaction alteration [CCC] | |
| 28212-9 | | Social isolation [CCC] | |
| 28213-7 | | Spiritual distress [CCC] | |
| 28214-5 | | Spiritual state alteration [CCC] | |
| 28215-2 | | Stress urinary incontinence [CCC] | |
| 28216-0 | | Suffocation risk [CCC] | |
| 28217-8 | | Sanitation Behavior Family [OMAHA] | |
| 28218-6 | | Sanitation Knowledge Family [OMAHA] | |
| 28219-4 | | Sanitation Status Family [OMAHA] | |
| 28220-2 | | Residence Behavior Family [OMAHA] | |
| 28221-0 | | Residence Knowledge Family [OMAHA] | |
| 28222-8 | | Residence Status Family [OMAHA] | |
| 28223-6 | | Neighborhood/workplace safety.behavior Family [OMAHA] | |
| 28224-4 | | Neighborhood/workplace safety..knowledge Family [OMAHA] | |
| 28225-1 | | Neighborhood/workplace safety.status Family [OMAHA] | |
| 28226-9 | | Swallowing impairment [CCC] | |
| 28227-7 | | Tactile alteration [CCC] | |
| 28228-5 | | Thermoregulation impairment [CCC] | |
| 28229-3 | | Thought process alteration [CCC] | |
| 28230-1 | | Tissue perfusion alteration [CCC] | |
| 28231-9 | | Toileting deficit [CCC] | |
| 28232-7 | | Total urinary incontinence [CCC] | |
| 28233-5 | | Trauma risk [CCC] | |
| 28234-3 | | Unilateral neglect [CCC] | |
| 28235-0 | | Constipation [CCC] | |
| 28236-8 | | Pain [CCC] | |
| 28237-6 | | Urge urinary incontinence [CCC] | |
| 28238-4 | | Urinary elimination alteration [CCC] | |
| 28239-2 | | Urinary retention [CCC] | |
| 28240-0 | | Verbal impairment [CCC] | |
| 28241-8 | | Violence risk [CCC] | |
| 28242-6 | | Visual alteration [CCC] | |
| 28243-4 | | Abuse Behavior [OMAHA] | |
| 28244-2 | | Abuse Knowledge [OMAHA] | |
| 28245-9 | | Abuse Status [OMAHA] | |
| 28246-7 | | Antepartum/postpartum.behavior [OMAHA] | |
| 28247-5 | | Antepartum/postpartum.status [OMAHA] | |
| 28248-3 | | Bowel Function Behavior [OMAHA] | |
| 28249-1 | | Bowel Function Knowledge [OMAHA] | |
| 28250-9 | | Bowel Function Status [OMAHA] | |
| 28251-7 | | Caretaking/parenting.behavior [OMAHA] | |
| 28252-5 | | Caretaking/parenting.knowledge [OMAHA] | |
| 28253-3 | | Caretaking/parenting.status [OMAHA] | |
| 28254-1 | | Circulation Behavior [OMAHA] | |
| 28255-8 | | Circulation Knowledge [OMAHA] | |
| 28256-6 | | Circulation Status [OMAHA] | |
| 28257-4 | | Cognition Behavior [OMAHA] | |
| 28258-2 | | Cognition Knowledge [OMAHA] | |
| 28259-0 | | Cognition Status [OMAHA] | |
| 28260-8 | | Communication With Community Resources Behavior [OMAHA] | |
| 28261-6 | | Communication With Community Resources Knowledge [OMAHA] | |
| 28262-4 | | Communication With Community Resources Status [OMAHA] | |
| 28263-2 | | Consciousness Behavior [OMAHA] | |
| 28264-0 | | Consciousness Knowledge [OMAHA] | |
| 28265-7 | | Consciousness Status [OMAHA] | |
| 28266-5 | | Dentition.behavior [OMAHA] | |
| 28267-3 | | Dentition.knowledge [OMAHA] | |
| 28268-1 | | Dentition.status [OMAHA] | |
| 28269-9 | | Digestion-hydration Behavior [OMAHA] | |
| 28270-7 | | Digestion-hydration Knowledge [OMAHA] | |
| 28271-5 | | Digestion-hydration Status [OMAHA] | |
| 28272-3 | | Mental Health Behavior [OMAHA] | |
| 28273-1 | | Mental Health Knowledge [OMAHA] | |
| 28274-9 | | Mental Health Status [OMAHA] | |
| 28275-6 | | Family Planning Behavior [OMAHA] | |
| 28276-4 | | Family Planning Knowledge [OMAHA] | |
| 28277-2 | | Family Planning Status [OMAHA] | |
| 28278-0 | | Genito-urinary function.behavior [OMAHA] | |
| 28279-8 | | Genito-urinary function.knowledge [OMAHA] | |
| 28280-6 | | Genito-urinary function.status [OMAHA] | |
| 28281-4 | | Grief Behavior [OMAHA] | |
| 28282-2 | | Grief Knowledge [OMAHA] | |
| 28283-0 | | Grief Status [OMAHA] | |
| 28284-8 | | Growth And Development Behavior [OMAHA] | |
| 28285-5 | | Growth And Development Knowledge [OMAHA] | |
| 28286-3 | | Growth And Development Status [OMAHA] | |
| 28287-1 | | Health Care Supervision Behavior [OMAHA] | |
| 28288-9 | | Health Care Supervision Knowledge [OMAHA] | |
| 28289-7 | | Health Care Supervision Status [OMAHA] | |
| 28290-5 | | Hearing Behavior [OMAHA] | |
| 28291-3 | | Hearing Knowledge [OMAHA] | |
| 28292-1 | | Hearing Status [OMAHA] | |
| 28293-9 | | Sexuality Behavior [OMAHA] | |
| 28294-7 | | Sexuality Knowledge [OMAHA] | |
| 28295-4 | | Sexuality Status [OMAHA] | |
| 28296-2 | | Income Behavior [OMAHA] | |
| 28297-0 | | Income Knowledge [OMAHA] | |
| 28298-8 | | Income Status [OMAHA] | |
| 28299-6 | | Skin Behavior [OMAHA] | |
| 28300-2 | | Skin Knowledge [OMAHA] | |
| 28301-0 | | Skin Status [OMAHA] | |
| 28302-8 | | Interpersonal Relationship Behavior [OMAHA] | |
| 28303-6 | | Interpersonal Relationship Knowledge [OMAHA] | |
| 28304-4 | | Interpersonal Relationship Status [OMAHA] | |
| 28305-1 | | Neglect Behavior [OMAHA] | |
| 28306-9 | | Neglect Knowledge [OMAHA] | |
| 28307-7 | | Neglect Status [OMAHA] | |
| 28308-5 | | Neighborhood/workplace safety.behavior [OMAHA] | |
| 28309-3 | | Neighborhood/workplace safety..knowledge [OMAHA] | |
| 28310-1 | | Neighborhood/workplace safety.status [OMAHA] | |
| 28311-9 | | Neuro-musculo-skeletal Function Behavior [OMAHA] | |
| 28312-7 | | Neuro-musculo-skeletal Function Knowledge [OMAHA] | |
| 28313-5 | | Neuro-musculo-skeletal Function Status [OMAHA] | |
| 28314-3 | | Nutrition Behavior [OMAHA] | |
| 28315-0 | | Nutrition Knowledge [OMAHA] | |
| 28316-8 | | Nutrition Status [OMAHA] | |
| 28317-6 | | Pain Behavior [OMAHA] | |
| 28318-4 | | Pain Knowledge [OMAHA] | |
| 28319-2 | | Pain Status [OMAHA] | |
| 28320-0 | | Personal Care Behavior [OMAHA] | |
| 28321-8 | | Personal Care Knowledge [OMAHA] | |
| 28322-6 | | Personal Care Status [OMAHA] | |
| 28323-4 | | Physical Activity Behavior [OMAHA] | |
| 28324-2 | | Physical Activity Knowledge [OMAHA] | |
| 28325-9 | | Physical Activity Status [OMAHA] | |
| 28326-7 | | Medication Regimen Behavior [OMAHA] | |
| 28327-5 | | Medication Regimen Knowledge [OMAHA] | |
| 28328-3 | | Medication Regimen Status [OMAHA] | |
| 28329-1 | | Residence Behavior [OMAHA] | |
| 28330-9 | | Residence Knowledge [OMAHA] | |
| 28331-7 | | Residence Status [OMAHA] | |
| 28332-5 | | Respiration Behavior [OMAHA] | |
| 28333-3 | | Respiration Knowledge [OMAHA] | |
| 28334-1 | | Respiration Status [OMAHA] | |
| 28335-8 | | Role Change Behavior [OMAHA] | |
| 28336-6 | | Role Change Knowledge [OMAHA] | |
| 28337-4 | | Role Change Status [OMAHA] | |
| 28338-2 | | Sanitation Behavior [OMAHA] | |
| 28339-0 | | Sanitation Knowledge [OMAHA] | |
| 28340-8 | | Sanitation Status [OMAHA] | |
| 28341-6 | | Sleep And Rest Pattern Behavior [OMAHA] | |
| 28342-4 | | Sleep And Rest Pattern Knowledge [OMAHA] | |
| 28343-2 | | Sleep And Rest Pattern Status [OMAHA] | |
| 28344-0 | | Social Contact Behavior [OMAHA] | |
| 28345-7 | | Social Contact Knowledge [OMAHA] | |
| 28346-5 | | Social Contact Status [OMAHA] | |
| 28347-3 | | Speech And Language Behavior [OMAHA] | |
| 28348-1 | | Speech And Language Knowledge [OMAHA] | |
| 28349-9 | | Speech And Language Status [OMAHA] | |
| 28350-7 | | Spirituality Behavior [OMAHA] | |
| 28351-5 | | Spirituality Knowledge [OMAHA] | |
| 28352-3 | | Spirituality Status [OMAHA] | |
| 28353-1 | | Substance Use Behavior [OMAHA] | |
| 28354-9 | | Substance Use Knowledge [OMAHA] | |
| 28355-6 | | Substance Use Status [OMAHA] | |
| 28356-4 | | Technical procedure.behavior [OMAHA] | |
| 28357-2 | | Technical procedure.knowledge [OMAHA] | |
| 28358-0 | | Technical procedure.status [OMAHA] | |
| 28359-8 | | Vision Behavior [OMAHA] | |
| 28360-6 | | Vision Knowledge [OMAHA] | |
| 28361-4 | | Vision Status [OMAHA] | |
| 28362-2 | | Anxiety [QAM] | |
| 28363-0 | | Fear [QAM] | |
| 28364-8 | | Afraid of pain and suffering [Living with HIV] | |
| 28365-5 | | Afraid to die [Living with HIV] | |
| 28366-3 | | Comfortable and well cared for [Living with HIV] | |
| 28367-1 | | Don't want high technology to keep me alive [Living with HIV] | |
| 28368-9 | | Don't have to keep fighting [Living with HIV] | |
| 28369-7 | | Embarrassed by the way I look [Living with HIV] | |
| 28370-5 | | Extra effort to do things [Living with HIV] | |
| 28371-3 | | Feel spiritual as I near the end [Living with HIV] | |
| 28372-1 | | Financial situation is distressing [Living with HIV] | |
| 28373-9 | | Frightened over little control [Living with HIV] | |
| 28374-7 | | Giving up things [Living with HIV] | |
| 28375-4 | | Anxiety [HIV-SSC] | |
| 28376-2 | | Chills [HIV-SSC] | |
| 28377-0 | | Day sweats [HIV-SSC] | |
| 28378-8 | | Depression [HIV-SSC] | |
| 28379-6 | | Diarrhea [HIV-SSC] | |
| 28380-4 | | Difficulty concentrating [HIV-SSC] | |
| 28381-2 | | Disorientation [HIV-SSC] | |
| 28382-0 | | Dry mouth [HIV-SSC] | |
| 28383-8 | | Fatigue [HIV-SSC] | |
| 28384-6 | | Fear [HIV-SSC] | |
| 28385-3 | | Fever [HIV-SSC] | |
| 28386-1 | | Gas /bloating [HIV-SSC] | |
| 28387-9 | | Lack of appetite [HIV-SSC] | |
| 28388-7 | | Loose stools [HIV-SSC] | |
| 28389-5 | | Memory loss [HIV-SSC] | |
| 28390-3 | | Muscle aches [HIV-SSC] | |
| 28391-1 | | Nausea [HIV-SSC] | |
| 28392-9 | | Night sweats [HIV-SSC] | |
| 28393-7 | | Painful joints [HIV-SSC] | |
| 28394-5 | | Shortness of breath at rest [HIV-SSC] | |
| 28395-2 | | Shortness of breath with activity [HIV-SSC] | |
| 28396-0 | | Thirsty [HIV-SSC] | |
| 28397-8 | | Vomiting [HIV-SSC] | |
| 28398-6 | | Weakness [HIV-SSC] | |
| 28399-4 | | Wheezing [HIV-SSC] | |
| 28400-0 | | I live for today [Living with HIV] | |
| 28401-8 | | Important to be in charge [Living with HIV] | |
| 28402-6 | | Important to be surrounded by those I love [Living with HIV] | |
| 28403-4 | | Independence [Living with HIV] | |
| 28404-2 | | Live life day to day [Living with HIV] | |
| 28405-9 | | Losing my looks is devastating [Living with HIV] | |
| 28406-7 | | Loss of independence [Living with HIV] | |
| 28407-5 | | Lots of regrets [Living with HIV] | |
| 28408-3 | | Toileting [QAM] | |
| 28409-1 | | Dressing [QAM] | |
| 28410-9 | | Grooming [QAM] | |
| 28411-7 | | Personal hygiene [QAM] | |
| 28412-5 | | Physical performance [QAM] | |
| 28413-3 | | Ambulation [QAM] | |
| 28414-1 | | Activity [QAM] | |
| 28415-8 | | Communication With Community Resources Behavior Family [OMAHA] | |
| 28416-6 | | Communication With Community Resources Knowledge Family [OMAHA] | |
| 28417-4 | | Communication With Community Resources Status Family [OMAHA] | |
| 28418-2 | | Social Contact Behavior Family [OMAHA] | |
| 28419-0 | | Social Contact Knowledge Family [OMAHA] | |
| 28420-8 | | Social Contact Status Family [OMAHA] | |
| 28421-6 | | Role Change Behavior Family [OMAHA] | |
| 28422-4 | | Role Change Knowledge Family [OMAHA] | |
| 28423-2 | | Role Change Status Family [OMAHA] | |
| 28424-0 | | Interpersonal Relationship Knowledge Family [OMAHA] | |
| 28425-7 | | Interpersonal Relationship Status Family [OMAHA] | |
| 28426-5 | | Neglect Behavior Family [OMAHA] | |
| 28427-3 | | Spirituality Behavior Family [OMAHA] | |
| 28428-1 | | Spirituality Knowledge Family [OMAHA] | |
| 28429-9 | | Spirituality Status Family [OMAHA] | |
| 28430-7 | | Grief Behavior Family [OMAHA] | |
| 28431-5 | | Grief Knowledge Family [OMAHA] | |
| 28432-3 | | Grief Status Family [OMAHA] | |
| 28433-1 | | Mental Health Behavior Family [OMAHA] | |
| 28434-9 | | Mental Health Knowledge Family [OMAHA] | |
| 28435-6 | | Mental Health Status Family [OMAHA] | |
| 28436-4 | | Sexuality Behavior Family [OMAHA] | |
| 28437-2 | | Sexuality Knowledge Family [OMAHA] | |
| 28438-0 | | Sexuality Status Family [OMAHA] | |
| 28439-8 | | Interpersonal Relationship Behavior Family [OMAHA] | |
| 28440-6 | | Caretaking/parenting.behavior Family [OMAHA] | |
| 28441-4 | | Caretaking/parenting.knowledge Family [OMAHA] | |
| 28442-2 | | Caretaking/parenting.status Family [OMAHA] | |
| 28443-0 | | Neglect Knowledge Family [OMAHA] | |
| 28444-8 | | Neglect Status Family [OMAHA] | |
| 28445-5 | | Abuse Behavior Family [OMAHA] | |
| 28446-3 | | Abuse Knowledge Family [OMAHA] | |
| 28447-1 | | Abuse Status Family [OMAHA] | |
| 28448-9 | | Growth And Development Behavior Family [OMAHA] | |
| 28449-7 | | Growth And Development Knowledge Family [OMAHA] | |
| 28450-5 | | Growth And Development Status Family [OMAHA] | |
| 28451-3 | | Hearing Behavior Family [OMAHA] | |
| 28452-1 | | Hearing Status Family [OMAHA] | |
| 28453-9 | | Vision Behavior Family [OMAHA] | |
| 28454-7 | | Vision Knowledge Family [OMAHA] | |
| 28455-4 | | Vision Status Family [OMAHA] | |
| 28456-2 | | Speech And Language Behavior Family [OMAHA] | |
| 28457-0 | | Speech And Language Knowledge Family [OMAHA] | |
| 28458-8 | | Speech And Language Status Family [OMAHA] | |
| 28459-6 | | Dentition.behavior Family [OMAHA] | |
| 28460-4 | | Dentition.knowledge Family [OMAHA] | |
| 28461-2 | | Dentition.status Family [OMAHA] | |
| 28462-0 | | Cognition Behavior Family [OMAHA] | |
| 28463-8 | | Cognition Knowledge Family [OMAHA] | |
| 28464-6 | | Cognition Status Family [OMAHA] | |
| 28465-3 | | Pain Behavior Family [OMAHA] | |
| 28466-1 | | Pain Knowledge Family [OMAHA] | |
| 28467-9 | | Pain Status Family [OMAHA] | |
| 28468-7 | | Consciousness Behavior Family [OMAHA] | |
| 28469-5 | | Consciousness Knowledge Family [OMAHA] | |
| 28470-3 | | Consciousness Status Family [OMAHA] | |
| 28471-1 | | Skin Behavior Family [OMAHA] | |
| 28472-9 | | Skin Knowledge Family [OMAHA] | |
| 28473-7 | | Skin Status Family [OMAHA] | |
| 28474-5 | | Neuro-musculo-skeletal Function Behavior Family [OMAHA] | |
| 28475-2 | | Neuro-musculo-skeletal Function Knowledge Family [OMAHA] | |
| 28476-0 | | Neuro-musculo-skeletal Function Status Family [OMAHA] | |
| 28477-8 | | Respiration Behavior Family [OMAHA] | |
| 28478-6 | | Respiration Knowledge Family [OMAHA] | |
| 28479-4 | | Respiration Status Family [OMAHA] | |
| 28480-2 | | Circulation Behavior Family [OMAHA] | |
| 28481-0 | | Circulation Knowledge Family [OMAHA] | |
| 28482-8 | | Circulation Status Family [OMAHA] | |
| 28483-6 | | Digestion-hydration Behavior Family [OMAHA] | |
| 28484-4 | | Digestion-hydration Knowledge Family [OMAHA] | |
| 28485-1 | | Digestion-hydration Status Family [OMAHA] | |
| 28486-9 | | Bowel Function Behavior Family [OMAHA] | |
| 28487-7 | | Bowel Function Knowledge Family [OMAHA] | |
| 28488-5 | | Bowel Function Status Family [OMAHA] | |
| 28489-3 | | Genito-urinary function.behavior Family [OMAHA] | |
| 28490-1 | | Genito-urinary function.knowledge Family [OMAHA] | |
| 28491-9 | | Genito-urinary function.status Family [OMAHA] | |
| 28492-7 | | Antepartum/postpartum.behavior Family [OMAHA] | |
| 28493-5 | | Antepartum/postpartum.status Family [OMAHA] | |
| 28494-3 | | Antepartum/postpartum.knowledge Family [OMAHA] | |
| 28495-0 | | Nutrition Behavior Family [OMAHA] | |
| 28496-8 | | Nutrition Knowledge Family [OMAHA] | |
| 28497-6 | | Nutrition Status Family [OMAHA] | |
| 28498-4 | | Sleep And Rest Pattern Behavior Family [OMAHA] | |
| 28499-2 | | Sleep And Rest Pattern Knowledge Family [OMAHA] | |
| 28500-7 | | Sleep And Rest Pattern Status Family [OMAHA] | |
| 28501-5 | | Physical Activity Behavior Family [OMAHA] | |
| 28502-3 | | Physical Activity Knowledge Family [OMAHA] | |
| 28503-1 | | Physical Activity Status Family [OMAHA] | |
| 28504-9 | | Personal Care Behavior Family [OMAHA] | |
| 28505-6 | | Personal Care Knowledge Family [OMAHA] | |
| 28506-4 | | Personal Care Status Family [OMAHA] | |
| 28507-2 | | Substance Use Behavior Family [OMAHA] | |
| 28508-0 | | Substance Use Knowledge Family [OMAHA] | |
| 28509-8 | | Substance Use Status Family [OMAHA] | |
| 28510-6 | | Family Planning Behavior Family [OMAHA] | |
| 28511-4 | | Family Planning Knowledge Family [OMAHA] | |
| 28512-2 | | Family Planning Status Family [OMAHA] | |
| 28513-0 | | Health Care Supervision Behavior Family [OMAHA] | |
| 28514-8 | | Health Care Supervision Knowledge Family [OMAHA] | |
| 28515-5 | | Health Care Supervision Status Family [OMAHA] | |
| 28516-3 | | Medication Regimen Behavior Family [OMAHA] | |
| 28517-1 | | Medication Regimen Knowledge Family [OMAHA] | |
| 28518-9 | | Medication Regimen Status Family [OMAHA] | |
| 28519-7 | | Technical procedure.behavior Family [OMAHA] | |
| 28520-5 | | Technical procedure.knowledge Family [OMAHA] | |
| 28521-3 | | Technical procedure.status Family [OMAHA] | |
| 28522-1 | | Income Status Family [OMAHA] | |
| 28523-9 | | Noncompliance with fluid volume [CCC] | |
| 28524-7 | | Noncompliance with medication regimen [CCC] | |
| 28525-4 | | Socialization alteration [CCC] | |
| 28526-2 | | Skin integrity alteration [CCC] | |
| 28527-0 | | Family embarrassed [Living with HIV] | |
| 28528-8 | | No good church experience [Living with HIV] | |
| 28529-6 | | Strength from family [Living with HIV] | |
| 28530-4 | | Family does what needs done [Living with HIV] | |
| 28531-2 | | My hometown means a lot [Living with HIV] | |
| 28532-0 | | No purpose in life [Living with HIV] | |
| 28533-8 | | Antepartum/postpartum.knowledge [OMAHA] | |
| 28534-6 | | Bathing [QAM] | |
| 28535-3 | | Income Knowledge Family [OMAHA] | |
| 28536-1 | | Income Behavior Family [OMAHA] | |
| 28537-9 | | Hearing Knowledge Family [OMAHA] | |
| 28538-7 | | Abdominal pain [HIV-SSC] | |
| 42819-3 | | Failure to thrive [CCC] | |
| 42820-1 | | Intracranial adaptive capacity impairment [CCC] | |
| 42821-9 | | Caregiver role strain Caregiver [CCC] | |
| 42822-7 | | Relocation stress syndrome [CCC] | |
| 42823-5 | | Suicide risk [CCC] | |
| 42824-3 | | Self mutilation risk [CCC] | |
| 42825-0 | | Perioperative injury risk [CCC] | |
| 42826-8 | | Perioperative positioning injury [CCC] | |
| 42827-6 | | Surgical recovery delay [CCC] | |
| 42828-4 | | Substance abuse [CCC] | |
| 42829-2 | | Tobacco abuse [CCC] | |
| 42830-0 | | Alcohol abuse [CCC] | |
| 42831-8 | | Drug abuse [CCC] | |
| 42832-6 | | Latex allergy response [CCC] | |
| 42833-4 | | Reproductive risk [CCC] | |
| 42834-2 | | Fertility risk [CCC] | |
| 42835-9 | | Infertility risk [CCC] | |
| 42836-7 | | Contraception risk [CCC] | |
| 42837-5 | | Perinatal risk [CCC] | |
| 42838-3 | | Pregnancy risk [CCC] | |
| 42839-1 | | Labor risk [CCC] | |
| 42840-9 | | Delivery risk [CCC] | |
| 42841-7 | | Postpartum risk [CCC] | |
| 42842-5 | | Newborn behavior alteration [CCC] | |
| 42843-3 | | Infant behavior alteration [CCC] | |
| 42844-1 | | Child behavior alteration [CCC] | |
| 42845-8 | | Adolescent behavior alteration [CCC] | |
| 42846-6 | | Adult behavior alteration [CCC] | |
| 42847-4 | | Sleep deprivation [CCC] | |
| 42848-2 | | Nausea [CCC] | |
| 42849-0 | | Confusion [CCC] | |
| 42850-8 | | Memory impairment [CCC] | |
| 42851-6 | | Infant feeding pattern impairment [CCC] | |
| 42852-4 | | Older adult behavior alteration.sixty five years and older [CCC] | |
| 42853-2 | | Ventilatory weaning impairment [CCC] | |
| 42854-0 | | Community coping impairment Community [CCC] | |
| 44249-1 | | PHQ-9 quick depression assessment panel [Reported.PHQ] | |
| 44250-9 | | Little interest or pleasure in doing things in last 2 weeks | |
| 44251-7 | | Poor appetite or overeating in last 2 weeks [Reported.PHQ] | |
| 44252-5 | | Trouble concentrating on things, such as reading the newspaper or watching television in last 2 weeks [Reported.PHQ] | |
| 44253-3 | | Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2 weeks [Reported.PHQ] | |
| 44254-1 | | Feeling tired or having little energy in last 2 weeks [Reported.PHQ] | |
| 44255-8 | | Feeling down, depressed, or hopeless in last 2 weeks | |
| 44256-6 | | Perceived difficulty in last 2 weeks [Reported.PHQ] | |
| 44257-4 | | Deprecated Patient Health Questionnaire 9 item (PHQ-9) [Reported] | |
| 44258-2 | | Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2 weeks [Reported.PHQ] | |
| 44259-0 | | Trouble falling or staying asleep, or sleeping too much in last 2 weeks [Reported.PHQ] | |
| 44260-8 | | Thoughts that you would be better off dead, or of hurting yourself in some way in last 2 weeks [Reported.PHQ] | |
| 44261-6 | | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | |
| 44262-4 | | Deprecated PHQ-9 interpretation | |
| 45399-3 | | Federal provider number Facility | |
| 45405-8 | | Ability to understand others [Minimum Data Set] | |
| 45406-6 | | Change in communication/hearing [Minimum Data Set] | |
| 45407-4 | | Vision [Minimum Data Set] | |
| 45408-2 | | Primary reason for assessment [Minimum Data Set (MDS) basic] | |
| 45409-0 | | Codes for assessments required for Medicare PPS or the State [Minimum Data Set] | |
| 45410-8 | | Admitted from (at entry) Facility [Minimum Data Set] | |
| 45411-6 | | Lived alone prior to admission [Minimum Data Set] | |
| 45412-4 | | History of prior stay at this nursing home [Minimum Data Set] | |
| 45413-2 | | History of stay in other nursing home [Minimum Data Set] | |
| 45414-0 | | History of stay in other residential facility [Minimum Data Set] | |
| 45415-7 | | History of stay at mental health/psychiatric setting [Minimum Data Set] | |
| 45416-5 | | History of stay in mental retardation and developmental disabilities setting [Minimum Data Set] | |
| 45417-3 | | None of the listed prior residential settings [Minimum Data Set] | |
| 45418-1 | | Deprecated Lifetime occupations [CMS Assessment] | |
| 45419-9 | | Language.other [Minimum Data Set] | |
| 45420-7 | | Mental health history [Minimum Data Set] | |
| 45421-5 | | No mental retardation and developmental disabilities [Minimum Data Set] | |
| 45422-3 | | Down's syndrome [Minimum Data Set] | |
| 45423-1 | | Autism [Minimum Data Set] | |
| 45424-9 | | Epilepsy [Minimum Data Set] | |
| 45425-6 | | Other organic condition related to mental retardation and developmental disabilities [Minimum Data Set] | |
| 45426-4 | | Mental retardation and developmental disabilities with no organic condition [Minimum Data Set] | |
| 45427-2 | | Date background information form completed [Minimum Data Set] | |
| 45428-0 | | Stays up late at night [Minimum Data Set] | |
| 45429-8 | | Naps regularly during day [Minimum Data Set] | |
| 45430-6 | | Goes out 1 or more days a week [Minimum Data Set] | |
| 45431-4 | | Stays busy with hobbies, reading or fixed daily routine [Minimum Data Set] | |
| 45432-2 | | Spends most time alone or watching TV [Minimum Data Set] | |
| 45433-0 | | Moves independently indoors [Minimum Data Set] | |
| 45434-8 | | Use of tobacco products at least daily [Minimum Data Set] | |
| 45435-5 | | None of the listed cycle of daily events [Minimum Data Set] | |
| 45436-3 | | Distinct food preferences [Minimum Data Set] | |
| 45437-1 | | Eats between meals all or most days [Minimum Data Set] | |
| 45438-9 | | Use of alcohol at least weekly [Minimum Data Set] | |
| 45439-7 | | None of the listed eating patterns [Minimum Data Set] | |
| 45440-5 | | In bedclothes much of day [Minimum Data Set] | |
| 45441-3 | | Wakens to toilet all or most nights [Minimum Data Set] | |
| 45442-1 | | Has irregular bowel movement pattern [Minimum Data Set] | |
| 45443-9 | | Showers for bathing [Minimum Data Set] | |
| 45444-7 | | Bathing in PM [Minimum Data Set] | |
| 45445-4 | | None of the listed additional ADL patterns [Minimum Data Set] | |
| 45446-2 | | Daily contact with relatives/close friends [Minimum Data Set] | |
| 45447-0 | | Usually attends church, temple, etc. [Minimum Data Set] | |
| 45448-8 | | Finds strength in faith [Minimum Data Set] | |
| 45449-6 | | Daily animal companion/presence [Minimum Data Set] | |
| 45450-4 | | Involved in group activities [Minimum Data Set] | |
| 45451-2 | | None of the listed involvement patterns [Minimum Data Set] | |
| 45452-0 | | Unknown customary routine - resident/family unable to provide information [Minimum Data Set] | |
| 45453-8 | | Date of last day of MDS observation period [Minimum Data Set] | |
| 45454-6 | | Original or corrected copy of form # [Minimum Data Set] | |
| 45455-3 | | Date of reentry to facility [Minimum Data Set] | |
| 45456-1 | | Medicaid per diem [Minimum Data Set] | |
| 45457-9 | | Medicare per diem [Minimum Data Set] | |
| 45458-7 | | Medicare ancillary part A [Minimum Data Set] | |
| 45459-5 | | Medicare ancillary part B [Minimum Data Set] | |
| 45460-3 | | CHAMPUS Per Diem [Minimum Data Set] | |
| 45461-1 | | VA Per Diem [Minimum Data Set] | |
| 45462-9 | | Self or family pays for full per diem [Minimum Data Set] | |
| 45463-7 | | Medicaid resident liability or Medicare copayment [Minimum Data Set] | |
| 45464-5 | | Private insurance per diem [Minimum Data Set] | |
| 45465-2 | | Other per diem [Minimum Data Set] | |
| 45466-0 | | Legal guardian [Minimum Data Set] | |
| 45467-8 | | Other legal oversight [Minimum Data Set] | |
| 45468-6 | | Health care durable power attorney [Minimum Data Set] | |
| 45469-4 | | Financial durable power attorney [Minimum Data Set] | |
| 45470-2 | | Family member responsible [Minimum Data Set] | |
| 45471-0 | | Patient responsible for self [Minimum Data Set] | |
| 45472-8 | | Responsibility - none of above [Minimum Data Set] | |
| 45474-4 | | Advance directive - do not resuscitate [Minimum Data Set] | |
| 45475-1 | | Advance directive - do not hospitalize [Minimum Data Set] | |
| 45476-9 | | Advance directive - organ donation [Minimum Data Set] | |
| 45477-7 | | Advance directive - autopsy request [Minimum Data Set] | |
| 45478-5 | | Advance directive - feeding restrictions [Minimum Data Set] | |
| 45479-3 | | Advance directive - medication restrictions [Minimum Data Set] | |
| 45480-1 | | Advance directive - other treatment restrictions [Minimum Data Set] | |
| 45481-9 | | Advance directive - none [Minimum Data Set] | |
| 45482-7 | | Comatose [CMS Assessment] | |
| 45483-5 | | Short-term memory OK [Minimum Data Set] | |
| 45484-3 | | Long-term memory OK [Minimum Data Set] | |
| 45485-0 | | Can recall current season [Minimum Data Set] | |
| 45486-8 | | Can recall location of own room [Minimum Data Set] | |
| 45487-6 | | Can recall staff names/faces [Minimum Data Set] | |
| 45488-4 | | Can recall that he or she is in nursing home [Minimum Data Set] | |
| 45489-2 | | Memory/recall - none of above are recalled [Minimum Data Set] | |
| 45490-0 | | Cognitive skills for daily decision making [Minimum Data Set] | |
| 45491-8 | | Easily distracted [Minimum Data Set] | |
| 45492-6 | | Periods of altered perception or awareness of surroundings [Minimum Data Set] | |
| 45493-4 | | Episodes of disorganized speech [Minimum Data Set] | |
| 45494-2 | | Periods of restlessness [Minimum Data Set] | |
| 45495-9 | | Periods of lethargy [Minimum Data Set] | |
| 45496-7 | | Mental function varies over the course of the day [Minimum Data Set] | |
| 45497-5 | | Change in cognitive status [Minimum Data Set] | |
| 45498-3 | | Hearing [Minimum Data Set] | |
| 45499-1 | | Hearing aid present and used [Minimum Data Set] | |
| 45500-6 | | Hearing aid present and not used regularly [Minimum Data Set] | |
| 45501-4 | | Other receptive communication techniques used [Minimum Data Set] | |
| 45502-2 | | No communication device [Minimum Data Set] | |
| 45503-0 | | Uses speech [Minimum Data Set] | |
| 45504-8 | | Uses written messages to express or clarify needs [Minimum Data Set] | |
| 45505-5 | | Uses American sign language or Braille [Minimum Data Set] | |
| 45506-3 | | Uses signs/gestures/sounds [Minimum Data Set] | |
| 45507-1 | | Uses communication board [Minimum Data Set] | |
| 45508-9 | | Uses other modes of expression [Minimum Data Set] | |
| 45509-7 | | Modes of expression - none of above [Minimum Data Set] | |
| 45510-5 | | Making self understood [Minimum Data Set] | |
| 45511-3 | | Speech clarity [Minimum Data Set] | |
| 45512-1 | | Side vision problems [Minimum Data Set] | |
| 45513-9 | | Sees halos or rings around lights, flashes of light, or curtains over eyes [Minimum Data Set] | |
| 45514-7 | | No visual limitations [Minimum Data Set] | |
| 45515-4 | | Visual appliances [Minimum Data Set] | |
| 45516-2 | | Resident made negative statements [Minimum Data Set] | |
| 45517-0 | | Repetitive questions [Minimum Data Set] | |
| 45518-8 | | Repetitive verbalizations [Minimum Data Set] | |
| 45519-6 | | Persistent anger with self or others [Minimum Data Set] | |
| 45520-4 | | Self deprecation [Minimum Data Set] | |
| 45521-2 | | Expression of what appear to be unrealistic fears [Minimum Data Set] | |
| 45522-0 | | Recurrent statements that something terrible is about to happen [Minimum Data Set] | |
| 45523-8 | | Balance while sitting - position, trunk control [Minimum Data Set] | |
| 45524-6 | | Range of motion Neck [Minimum Data Set] | |
| 45525-3 | | Voluntary movement Neck [Minimum Data Set] | |
| 45526-1 | | Range of motion Upper extremity [Minimum Data Set] | |
| 45527-9 | | Voluntary movement Upper extremity [Minimum Data Set] | |
| 45528-7 | | Range of motion Hand [Minimum Data Set] | |
| 45529-5 | | Voluntary movement Hand [Minimum Data Set] | |
| 45530-3 | | Range of motion Lower extremity [Minimum Data Set] | |
| 45531-1 | | Voluntary movement Lower extremity [Minimum Data Set] | |
| 45532-9 | | Range of motion Foot [Minimum Data Set] | |
| 45533-7 | | Voluntary movement Foot [Minimum Data Set] | |
| 45534-5 | | Other limitation or loss - range of motion [Minimum Data Set] | |
| 45535-2 | | Other limitation or loss - voluntary movement [Minimum Data Set] | |
| 45536-0 | | Uses cane, walker or crutch [Minimum Data Set] | |
| 45537-8 | | Wheeled self [Minimum Data Set] | |
| 45538-6 | | Other person wheeled [Minimum Data Set] | |
| 45539-4 | | Wheelchair primary mode of locomotion [Minimum Data Set] | |
| 45540-2 | | No modes of locomotion [Minimum Data Set] | |
| 45541-0 | | Bedfast all or most of the time [Minimum Data Set] | |
| 45542-8 | | Bed rails used for bed mobility or transfer [Minimum Data Set] | |
| 45543-6 | | Lifted manually [Minimum Data Set] | |
| 45544-4 | | Lifted mechanically [Minimum Data Set] | |
| 45545-1 | | Transfer aid [Minimum Data Set] | |
| 45546-9 | | No mode of transfer [Minimum Data Set] | |
| 45547-7 | | Repetitive health complaints [Minimum Data Set] | |
| 45548-5 | | Repetitive anxious complaints or concerns [Minimum Data Set] | |
| 45549-3 | | Unpleasant mood in morning [Minimum Data Set] | |
| 45550-1 | | Insomnia/change in sleeping pattern [Minimum Data Set] | |
| 45551-9 | | Sad, pained, or worried facial expressions [Minimum Data Set] | |
| 45552-7 | | Crying or tearfulness [Minimum Data Set] | |
| 45553-5 | | Repetitive physical movements [Minimum Data Set] | |
| 45554-3 | | Withdrawal from activities of interest [Minimum Data Set] | |
| 45555-0 | | Reduced social interaction [Minimum Data Set] | |
| 45556-8 | | Mood persistence [Minimum Data Set] | |
| 45557-6 | | Change in mood [Minimum Data Set] | |
| 45558-4 | | Frequency of wandering [Minimum Data Set] | |
| 45559-2 | | Alterability of wandering [Minimum Data Set] | |
| 45560-0 | | Frequency of verbally abusive behavioral symptoms [Minimum Data Set] | |
| 45561-8 | | Alterability of verbally abusive behavioral symptoms [Minimum Data Set] | |
| 45562-6 | | Frequency of physically abusive behavioral symptoms [Minimum Data Set] | |
| 45563-4 | | Alterability of physically abusive behavioral symptoms [Minimum Data Set] | |
| 45564-2 | | Frequency of socially inappropriate or disruptive behavioral symptoms [Minimum Data Set] | |
| 45565-9 | | Alterability of socially inappropriate or disruptive behavioral symptoms [Minimum Data Set] | |
| 45566-7 | | Frequency of resists care [Minimum Data Set] | |
| 45567-5 | | Alterability of resists care [Minimum Data Set] | |
| 45568-3 | | Change in behavioral symptoms [Minimum Data Set] | |
| 45569-1 | | At ease interacting with others [Minimum Data Set] | |
| 45570-9 | | At ease doing planned or structured activities [Minimum Data Set] | |
| 45571-7 | | At ease doing self-initiated activities [Minimum Data Set] | |
| 45572-5 | | Establishes own goals [Minimum Data Set] | |
| 45573-3 | | Pursues involvement in life of facility [Minimum Data Set] | |
| 45574-1 | | Accepts invitations to most group activities [Minimum Data Set] | |
| 45575-8 | | Sense of initiative - none of above [Minimum Data Set] | |
| 45576-6 | | Covert/open conflict with or repeated criticism of staff [Minimum Data Set] | |
| 45577-4 | | Unhappy with roommate [Minimum Data Set] | |
| 45578-2 | | Unhappy with residents other than roommate [Minimum Data Set] | |
| 45579-0 | | Openly expresses conflict/anger with family/friends [Minimum Data Set] | |
| 45580-8 | | Absence of contact with family/friends [Minimum Data Set] | |
| 45581-6 | | Recent loss of close family member/friend [Minimum Data Set] | |
| 45582-4 | | Does not adjust easily to change in routines [Minimum Data Set] | |
| 45583-2 | | No unsettled relationships [Minimum Data Set] | |
| 45584-0 | | Strong identification with past roles and life status [Minimum Data Set] | |
| 45585-7 | | Expresses sadness/anger/empty feeling over lost roles/status [Minimum Data Set] | |
| 45586-5 | | Resident perceives that daily routine (customary routine, activities) is very different from prior pattern in the community [Minimum Data Set] | |
| 45587-3 | | Past roles - none of above [Minimum Data Set] | |
| 45588-1 | | Bed mobility - self-performance during assessment period [CMS Assessment] | |
| 45589-9 | | Bed mobility - support provided during assessment period [CMS Assessment] | |
| 45590-7 | | Transfer - self-performance during assessment period [CMS Assessment] | |
| 45591-5 | | Transfer - support provided during assessment period [CMS Assessment] | |
| 45592-3 | | Walk in room - self-performance during assessment period [CMS Assessment] | |
| 45593-1 | | Walk in room - support provided during assessment period [CMS Assessment] | |
| 45594-9 | | Walk in corridor - self-performance during assessment period [CMS Assessment] | |
| 45595-6 | | Walk in corridor - support provided during assessment period [CMS Assessment] | |
| 45596-4 | | Locomotion on unit - self-performance during assessment period [CMS Assessment] | |
| 45597-2 | | Locomotion on unit - support provided during assessment period [CMS Assessment] | |
| 45598-0 | | Locomotion off unit - self-performance during assessment period [CMS Assessment] | |
| 45599-8 | | Locomotion off unit - support provided during assessment period [CMS Assessment] | |
| 45600-4 | | Dressing - self-performance during assessment period [CMS Assessment] | |
| 45601-2 | | Dressing - support provided during assessment period [CMS Assessment] | |
| 45602-0 | | Eating - self-performance during assessment period [CMS Assessment] | |
| 45603-8 | | Eating - support provided during assessment period [CMS Assessment] | |
| 45604-6 | | Toilet use - self-performance during assessment period [CMS Assessment] | |
| 45605-3 | | Toilet use - support provided during assessment period [CMS Assessment] | |
| 45606-1 | | Personal hygiene - self-performance during assessment period [CMS Assessment] | |
| 45607-9 | | Personal hygiene - support provided during assessment period [CMS Assessment] | |
| 45608-7 | | Bathing - self-performance during assessment period [CMS Assessment] | |
| 45609-5 | | Bathing - support provided during assessment period [CMS Assessment] | |
| 45610-3 | | Balance while standing [Minimum Data Set] | |
| 45611-1 | | Task segmentation [Minimum Data Set] | |
| 45612-9 | | Resident believes he or she is capable of increased independence in at least some ADLs [Minimum Data Set] | |
| 45613-7 | | Direct care staff believe resident is capable of increased independence in at least some ADLs [CMS Assessment] | |
| 45614-5 | | Resident able to perform tasks or activity but is very slow [Minimum Data Set] | |
| 45615-2 | | Difference in ADL Self-Performance or ADL Support, comparing mornings to evenings [Minimum Data Set] | |
| 45616-0 | | Activities of daily living rehabilitation potential - none of above [Minimum Data Set] | |
| 45617-8 | | Change in activities of daily living function [Minimum Data Set] | |
| 45618-6 | | Bowel continence [Minimum Data Set] | |
| 45619-4 | | Bladder continence [Minimum Data Set] | |
| 45620-2 | | Bowel elimination pattern regular - at least one movement every three days [Minimum Data Set] | |
| 45621-0 | | Constipation [Minimum Data Set] | |
| 45622-8 | | Diarrhea [Minimum Data Set] | |
| 45623-6 | | Fecal impaction [Minimum Data Set] | |
| 45624-4 | | Bowel elimination pattern - none of above [Minimum Data Set] | |
| 45625-1 | | Any scheduled toileting plan [Minimum Data Set] | |
| 45626-9 | | Bladder retraining program [Minimum Data Set] | |
| 45627-7 | | External catheter [Minimum Data Set] | |
| 45628-5 | | Indwelling catheter [Minimum Data Set] | |
| 45629-3 | | Intermittent catheter [Minimum Data Set] | |
| 45630-1 | | Did not use toilet room/commode/urinal [Minimum Data Set] | |
| 45631-9 | | Pads/briefs used [Minimum Data Set] | |
| 45632-7 | | Enemas/irrigation [Minimum Data Set] | |
| 45633-5 | | Ostomy present [Minimum Data Set] | |
| 45634-3 | | Continence appliances and programs - none of above [Minimum Data Set] | |
| 45635-0 | | Change in urinary continence [Minimum Data Set] | |
| 45636-8 | | Diabetes mellitus [Minimum Data Set] | |
| 45637-6 | | Hyperthyroidism [Minimum Data Set] | |
| 45638-4 | | Hypothyroidism [Minimum Data Set] | |
| 45639-2 | | Arteriosclerotic heart disease [Minimum Data Set] | |
| 45640-0 | | Cardiac dysrhythmias [Minimum Data Set] | |
| 45641-8 | | Congestive heart failure [Minimum Data Set] | |
| 45642-6 | | Deep vein thrombosis [Minimum Data Set] | |
| 45643-4 | | Hypertension [Minimum Data Set] | |
| 45644-2 | | Hypotension [Minimum Data Set] | |
| 45645-9 | | Peripheral vascular disease [Minimum Data Set] | |
| 45646-7 | | Other cardiovascular disease [Minimum Data Set] | |
| 45647-5 | | Arthritis [Minimum Data Set] | |
| 45648-3 | | Hip fracture [Minimum Data Set] | |
| 45649-1 | | Missing limb [Minimum Data Set] | |
| 45650-9 | | Osteoporosis [Minimum Data Set] | |
| 45651-7 | | Pathological bone fracture [Minimum Data Set] | |
| 45652-5 | | Alzheimer's disease [Minimum Data Set] | |
| 45653-3 | | Aphasia [Minimum Data Set] | |
jurisdiction[0]